WO2023246485A1 - 3d stratum corneum-like model, construction method therefor and use thereof - Google Patents

3d stratum corneum-like model, construction method therefor and use thereof Download PDF

Info

Publication number
WO2023246485A1
WO2023246485A1 PCT/CN2023/098261 CN2023098261W WO2023246485A1 WO 2023246485 A1 WO2023246485 A1 WO 2023246485A1 CN 2023098261 W CN2023098261 W CN 2023098261W WO 2023246485 A1 WO2023246485 A1 WO 2023246485A1
Authority
WO
WIPO (PCT)
Prior art keywords
model
stratum corneum
cells
bacteria
keratinocytes
Prior art date
Application number
PCT/CN2023/098261
Other languages
French (fr)
Chinese (zh)
Inventor
吴建新
黄庆
王攀
Original Assignee
中国药科大学
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 中国药科大学 filed Critical 中国药科大学
Publication of WO2023246485A1 publication Critical patent/WO2023246485A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0697Artificial constructs associating cells of different lineages, e.g. tissue equivalents
    • C12N5/0698Skin equivalents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/06Quantitative determination
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00Use of cells in diagnostics
    • C12N2503/04Screening or testing on artificial tissues
    • C12N2503/06Screening or testing on artificial skin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2513/003D culture
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00Supports or coatings for cell culture, characterised by material
    • C12N2533/70Polysaccharides
    • C12N2533/80Hyaluronan
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2535/00Supports or coatings for cell culture characterised by topography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/10Screening for compounds of potential therapeutic value involving cells
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Definitions

  • the present invention relates to a cuticle-like model and its construction method and application, and in particular to a 3D cuticle-like model that can be colonized by a variety of microorganisms and its construction method and application.
  • the physiological state of the skin is divided into three categories: moist, oily and dry. Although the skin lacks nutrition, is acidic, and is dry, there are still 10 6 bacteria/cm 2 living on it. Most of the bacteria colonize the superficial part of the stratum corneum and use the cross-linked proteins and lipids of keratinocytes as a source of nutrition.
  • in vitro research on microecology mainly uses 3D epidermal models, which are constructed through the differentiation of human primary keratinocytes into human epidermal equivalents.
  • 3D epidermal models which are constructed through the differentiation of human primary keratinocytes into human epidermal equivalents.
  • they are mainly used for cosmetic safety evaluation; with the rise of bioprinting technology , research on using 3D bioprinting technology to construct new epidermal models is also gradually increasing.
  • bacteria stay on the surface of the skin, and symbiotic bacteria do not interfere with skin homeostasis. When the skin barrier is destroyed, bacteria penetrate the epidermal barrier and cause an inflammatory response.
  • a 3D stratum corneum-like model of the stratum corneum's physiological state for bacterial colonization There are no relevant patents or literature reports on the in vitro method of establishing a 3D stratum corneum model to evaluate the microecological regulation efficacy of cosmetic raw materials and finished products.
  • the 3D stratum corneum model established by the present invention can be established simply and quickly, and can also better maintain the composition and diversity of human skin microorganisms.
  • the current method for in vitro evaluation of regulating microecology mainly uses a 3D epidermal model to inoculate microorganisms as a model.
  • the 3D epidermal model used in this method is to use human primary keratinocytes to differentiate to form human epidermal equivalents, and the microorganisms are directly inoculated into the 3D epidermis.
  • the model is used to evaluate the efficacy of regulating microecology.
  • the currently used 3D epidermal models are relatively expensive and take a long time to produce.
  • Human primary keratinocytes need to differentiate for more than ten days to form a 3D epidermal model. Therefore, this method has the problems of high cost, low efficiency and time-consuming, and it is difficult to achieve high-throughput screening of active ingredients.
  • the purpose of the present invention is to provide a 3D stratum corneum-like model that is fast, stable and capable of high-throughput screening of active substances and can be colonized by a variety of microorganisms; another purpose of the present invention is to provide a 3D stratum corneum-like model.
  • Method for constructing a stratum corneum model; another object of the present invention is to provide the application of the above-mentioned 3D stratum corneum model in in vitro efficacy evaluation of cosmetics or their raw materials, efficacy screening of cosmetic active ingredients, or efficacy evaluation of biological preparations.
  • a 3D stratum corneum-like model of the present invention includes a photocurable gel skeleton, and the photocurable gel skeleton is loaded with apoptotic cells/or cell derivatives;
  • the photocurable gel skeleton is composed of biomacromolecules with double bonds in their side chains that can be cross-linked by irradiation with light.
  • the irradiation light used when the gel is cured is ultraviolet, blue light, gamma ray or near-infrared irradiation.
  • the biological macromolecules include GMHA (hyaluronic acid cross-linked glyceryl methacrylate), CMA (methacrylated collagen), CSMA (chondroitin sulfate methacrylate), GMA (methacrylic acid One or more of glycidyl ester) or HAMA (hyaluronic acid methacrylate).
  • GMHA hyaluronic acid cross-linked glyceryl methacrylate
  • CMA methacrylated collagen
  • CSMA chondroitin sulfate methacrylate
  • GMA methacrylic acid One or more of glycidyl ester
  • HAMA hyaluronic acid methacrylate
  • the 3D stratum corneum model is composed of a top surface, a middle layer and a bottom surface.
  • the top and bottom surfaces are uneven and composed of apoptotic cells and/or cell derivatives that are tightly connected through a photo-curable gel.
  • the middle layer uses a photocurable gel as a skeleton, and the photocurable gel skeleton constitutes several pores, and apoptotic cells and/or cell derivatives are distributed in the pores.
  • the pore diameter of the voids formed by the photocurable gel skeleton is 1-500 ⁇ m, preferably 50-150 ⁇ m.
  • the thickness of the 3D stratum corneum-like model is 10 ⁇ m to 1 mm.
  • the cells are sebaceous gland cells and skin keratinocytes, wherein the sebaceous gland cells are human primary sebaceous gland cells or human immortalized sebaceous gland cell lines, and the keratinocytes are human primary keratinocytes or human immortalized keratinocyte cell lines; the cell derivatives are cell fragments. and cellular metabolites.
  • skin keratinocytes account for 10% to 90% of the total cells in the 3D stratum corneum model.
  • the present invention provides a method for constructing the above-mentioned 3D stratum corneum-like model, which includes the following steps: light-curing a photocurable gel with apoptotic keratinocytes and sebaceous gland cells to obtain a 3D stratum corneum-like model.
  • the photocuring method is to add 0.15% to 0.3% photoinitiator to 5-50mg/mL photocurable gel, put it into a well plate, and add evenly mixed keratinocytes under the condition of light irradiation. and sebaceous gland cells, dried at constant temperature.
  • the photocuring method is to mix 0.15% to 0.3% photoinitiator with a certain number of keratinocytes and sebaceous gland cells, and the resulting mixed solution is added to 5 to 50 mg/mL GMHA and put into a well plate. in the light Dry at constant temperature under irradiation conditions.
  • the irradiation light used when the gel is cured is ultraviolet, blue light, gamma ray or near-infrared irradiation.
  • the present invention provides an application of the above-mentioned 3D stratum corneum model in in vitro efficacy evaluation of cosmetics or their raw materials, efficacy screening of cosmetic active ingredients, or efficacy evaluation of biological preparations.
  • the 3D stratum corneum model of the present invention can be colonized by a variety of microorganisms and can be used to evaluate the efficacy of cosmetics and raw materials in regulating the skin microbiome in vitro or to evaluate the antibacterial efficacy of antibiotic biological preparations.
  • the application method includes the following steps:
  • facial bacteria include but are not limited to Propionibacterium acnes, Staphylococcus epidermidis, Staphylococcus aureus, Malassezia, etc.;
  • the stratum corneum model of the present invention is formed based on photocurable hydrogel and apoptotic keratinocytes and sebaceous gland cells, and has been proven to be co-colonized by Propionibacterium acnes, Staphylococcus epidermidis, and Staphylococcus aureus. Growth can be used to evaluate the efficacy of cosmetics in regulating microecology and test the antibacterial efficacy of biological agents such as antibiotics.
  • the component of the photocurable hydrogel is one or more of CMA, GMHA, CSMA, GMA or HAMA.
  • the present invention Compared with the existing technology, the present invention has the following significant advantages: it uses methacrylated hyaluronic acid hydrogel and apoptotic HaCaT cells and sebaceous gland cells to form a structure similar to the stratum corneum and sebaceous glands after light curing. and a method for constructing a 3D cuticle-like model for microbial colonization and growth.
  • the established 3D stratum corneum-like model can be used in vitro to evaluate the efficacy of cosmetics in regulating microecology and test the antibacterial efficacy of biological agents such as antibiotics. It has the characteristics of low cost, relatively fast, stable and high-throughput screening of active substances.
  • Figure 1 is a simplified diagram of the 3D stratum corneum-like model of the present invention.
  • Figure 2 is the GMHA synthesis equation in Example 1;
  • Figure 3 is a schematic diagram of the surface of the model under 40 times magnification under an inverted microscope when the model was made according to Scheme 1 in Example 1;
  • Figure 4 is a schematic diagram of the surface of the model under 20 times magnification under an inverted microscope when the model was made according to Scheme 2 in Example 1;
  • Figure 5 is a schematic diagram of the model surface under a scanning electron microscope magnified 500 times in Example 1 according to Scheme 1;
  • Figure 6 is a schematic diagram of the model surface under a scanning electron microscope magnified 1000 times when the model was made according to Scheme 1 in Example 1;
  • Figure 7 is a model made according to Scheme 2 in Example 1, and the surface of the model under a scanning electron microscope is magnified 300 times. intention;
  • Figure 8 is a schematic diagram of the cross-sectional aperture of the model produced according to Scheme 2 in Example 1 and magnified 5000 times under a scanning electron microscope;
  • Figure 9 shows that in Example 2, about 1 ⁇ 10 6 CFU of Propionibacterium acnes was inoculated into the model and cultured in a 35°C biochemical incubator. On the 0th, 2nd, 3rd, 4th and 5th days of culture respectively Line chart of the number of detected bacteria;
  • Figure 10 shows the stratum corneum model in Example 2. Under a scanning electron microscope at 400 times, it is seen that the cells are cross-linked by GMHA to form a dense stratum corneum;
  • Figure 11 is a partial enlarged view of Figure 10, showing a schematic diagram of the establishment of a biofilm on the surface of the stratum corneum by Propionibacterium acnes, a common anaerobic bacterium on the face;
  • Figure 12 shows that in Example 2, 10 5 to 10 8 CFU of Propionibacterium acnes was inoculated into the model and cultured, and the total number of bacteria was detected on days 1, 3, 5, 7, and 9;
  • Figure 13 shows that in Example 2, 10 5 to 10 8 CFU of Staphylococcus epidermidis was inoculated into the model and cultured, and the total number of bacteria was detected on days 1, 3, 5, 7, and 9;
  • Figure 14 shows that in Example 2, 10 5 to 10 8 CFU of Staphylococcus aureus was inoculated into the model and cultured, and the total number of bacteria was detected on days 1, 3, 5, 7, and 9;
  • Figure 15 shows that in Example 2, about 1 ⁇ 10 7 CFU/mL of Staphylococcus aureus and Propionibacterium acnes were inoculated and cultured on the model, and the total number of bacteria was detected on days 1, 2, 3, 4, and 6;
  • Figure 16 shows the number of three types of bacteria after adding different lotion samples to the facial microecology established by co-culture of Propionibacterium acnes, Staphylococcus aureus, and Staphylococcus epidermidis.
  • Group 0 is the preservative-free lotion group;
  • NI- The 0.1 group is a lotion group containing 0.1% methylparaben;
  • the NI-0.2 group is a lotion group containing 0.2% methylparaben;
  • the BEN-0.6 group is a lotion group containing 0.6% phenoxyethanol;
  • BEN- Group 0.8 is a lotion group containing 0.8% phenoxyethanol.
  • Figure 17 shows a mixture of CMA gel and photoinitiator, which forms a solidified gel after being irradiated with UV light;
  • Figure 18 shows a mixture of CSMA gel and photoinitiator, which forms a solidified gel after being irradiated with UV light;
  • Figure 19 shows a mixture of a certain concentration of CMA or CSMA with human primary keratinocytes, human primary sebaceous gland cells, human primary fibroblasts, and human immortalized fibroblasts (HSF cells) and then mixed with Propionibacterium acnes in 96 wells.
  • (A) is a mixture of a certain concentration of CMA or CSMA and human primary keratinocytes, human primary sebaceous gland cells, human primary fibroblasts, and human immortalized fibroblasts (HSF). Cells) were mixed with P. acnes and cultured anaerobically in a 96-well plate for 48 hours;
  • (B) is a histogram of the absorbance of the P. acnes suspension after culture;
  • Figure 20 shows a mixture of a certain concentration of CMA or CSMA with human primary keratinocytes, human primary sebaceous gland cells, human primary fibroblasts, and human immortalized fibroblasts (HSF cells), and then mixed with Staphylococcus epidermidis in a 96-well plate.
  • Diagram of bacterial liquid cultured for 24 hours (A) is a mixture of a certain concentration of CMA or CSMA and human primary keratinocytes, Human primary sebaceous gland cells, human primary fibroblasts, and human immortalized fibroblasts (HSF cells) were mixed and cultured with Staphylococcus epidermidis in a 96-well plate for 24 hours; (B) is the suspension of Staphylococcus epidermidis after culture. Liquid absorbance histogram;
  • Figure 21 is a diagram of the growth of Malassezia on the model.
  • Figure 22 is a graph of the differences between the three groups on days 0, 1, and 4 of culture.
  • the figure shows the distribution box plot of the distance between samples in the group on day 0 and the difference between the sample on day 0 and the sample on day 1 or 4. Box plot of distances between samples on day 4.
  • the meanings of each symbol are as follows: the upper and lower end lines of the box, the upper and lower interquartile range (IQR); the median line, the median; the upper and lower edges, the maximum and minimum values (1.5 times the IQR range). extreme values within); points outside the upper and lower edges represent outliers.
  • IQR interquartile range
  • the median line the median
  • the upper and lower edges the maximum and minimum values (1.5 times the IQR range). extreme values within)
  • points outside the upper and lower edges represent outliers.
  • Figure 23 is an NMDS analysis diagram. Each point in the diagram represents a sample, and points of different shapes indicate different samples (groups). NMDS adopts hierarchical sorting, which can be approximated to mean that the closer (far) the distance between two points is, the smaller (larger) the difference in the microbial communities in the two samples is.
  • the elliptical dotted circle is the 95% confidence ellipse (that is, 95 out of 100 samples of this sample group will fall within it).
  • Figure 24 is a histogram of the top twenty species compositions at the genus level relative abundance of the three groups of bacterial groups on days 0, 1 and 4 of culture.
  • the abscissa in the figure is the name of each group, and the ordinate is the relative abundance of each taxon at the genus level.
  • a 3D stratum corneum-like model is provided.
  • the 3D stratum corneum-like model is composed of a top surface 1, a middle layer 2 and a bottom surface 3.
  • the surfaces of the top surface 1 and the bottom surface 3 are uneven. It is composed of apoptotic cells and/or cell derivatives that are tightly connected through a photo-curable gel.
  • the middle layer uses the photo-curable gel as a skeleton 5.
  • the skeleton 5 of the photo-curable gel forms a number of gaps distributed within the gaps.
  • Cells 4 are apoptotic cells and/or cell derivatives; cells 4 are closely arranged within the skeleton 5 of the photocurable gel, forming a certain closed space for the growth of anaerobic bacteria; the photocurable gel
  • the pore diameter of the voids formed by the skeleton 5 is 1 to 500 ⁇ m, preferably 50 to 150 ⁇ m; the thickness of the intermediate layer 2 is 10 ⁇ m to 1 mm.
  • the photocurable gel skeleton is composed of biological macromolecules whose side chains contain double bonds that can be cross-linked by irradiation of light. All can achieve the purpose of the present invention.
  • the biological macromolecule is GMHA, CMA, CSMA, GMA or HAMA.
  • the irradiation light used when the gel is cured is ultraviolet, blue light, gamma ray or near-infrared irradiation.
  • the cells are preferably sebaceous gland cells and HaCaT cells.
  • HaCaT cells account for 10-90% of the total cells in the 3D stratum corneum model.
  • a method for constructing a 3D stratum corneum-like model is provided.
  • GMHA, HaCaT cells and sebaceous gland cells are photocured to obtain a 3D stratum corneum-like model.
  • the application of a 3D stratum corneum model in in vitro efficacy evaluation of cosmetics or their raw materials, efficacy screening of cosmetic active ingredients, or efficacy evaluation of biological preparations is provided.
  • the application method described therein includes the following steps:
  • Facial bacteria include, but are not limited to, Propionibacterium acnes, Staphylococcus epidermidis, Staphylococcus aureus, Malassezia, etc.
  • HaCaT cells refer to human immortalized keratinocytes, which are immortalized keratinocytes derived from non-tumor human normal skin and have similar differentiation characteristics to normal human keratinocytes.
  • PMA-qPCR quantitative detection uses propidium bromide azide (PMA) to bind firmly to the DNA of dead cells.
  • the DNA combined with PMA will not amplify during the PCR reaction. Therefore, PMA combined with real-time quantitative PCR (PMA-qPCR) can eliminate the interference of dead cells and only quantify the DNA of living cells.
  • GMHA is a hydrogel formed by cross-linking methacrylated hyaluronic acid.
  • This embodiment provides a method for constructing a 3D stratum corneum-like model, which includes the following steps:
  • HaCaT cells and sebaceous gland cell culture steps HaCaT cells and sebaceous gland cells are cultured in DMEM complete culture medium in a CO 2 incubator at 37 ⁇ 0.5°C, 5% CO 2 and saturated humidity until HaCaT cells and sebaceous gland cells fuse. Collect cells when the concentration reaches 80%-90%, remove the original culture medium, add PBS buffer to rinse twice, add EDTA-containing trypsin for digestion for 6 to 8 minutes, add complete culture medium to terminate digestion, centrifuge to collect cells, and rinse with PBS buffer Rinse twice and remove culture medium.
  • reaction solution was transferred to a dialysis bag (cutoff 3.5 ⁇ 10 3 Da) and dialyzed with double-distilled water for three days, changing the double-distilled water every 12 hours.
  • the dialyzed reaction solution is freeze-dried to obtain GMHA freeze-dried product.
  • Steps for establishing stratum corneum Plan 1: Take 100 ⁇ L of 5-20 mg/mL GMHA and add 0.15%-0.3% LAP, put it into a 24-well plate, irradiate it under a UV lamp for 5-15 minutes, and add evenly mixed 6 ⁇ 10 5 HaCaT cells and 6 ⁇ 10 4 sebaceous gland cells were dried at 37°C for 24 to 48 hours.
  • Option 2 Take 100 ⁇ L of 5-20 mg/mL GMHA, add a mixture containing 0.15%-0.3% LAP, 6 ⁇ 10 5 HaCaT cells and 6 ⁇ 10 4 sebaceous gland cells, and place it into a 24-well plate. Irradiate under ultraviolet lamp for 5 to 15 minutes and dry at 37°C for 24 to 48 hours.
  • the obtained 3D stratum corneum-like model is shown in Figures 4, 6, and 8.
  • the above methods will form a layer of composite material containing a large number of keratinocytes.
  • the GMHA gel closely connects the cells and cell derivatives to form a tight keratin-like layer with a thickness of 10 ⁇ m ⁇ 1 mm and an uneven surface.
  • the gel has a thickness of 50 ⁇ With a pore size of 150 ⁇ m, cells can be closely arranged within the pore to form a dense and certain closed space inside.
  • This model can provide a suitable growth environment for anaerobic bacteria and aerobic bacteria on the skin, and microorganisms can grow together on the model. .
  • the method for constructing a 3D stratum corneum-like model includes the following steps:
  • GMHA synthesis Dissolve 1g hyaluronic acid in 100mL PBS buffer, add 7.5mL triethylamine, 7.5g tetrabutylammonium bromide, and 7.5mL glycidyl methacrylate to the hyaluronic acid solution in sequence .
  • triethylamine is the catalyst
  • tetrabutylammonium bromide is the phase transfer catalyst.
  • Set the reaction temperature to 20°C and react for 30 to 40 hours with constant stirring. After the reaction, the reaction solution was transferred to a dialysis bag (cutoff 3.5 ⁇ 10 3 Da) and dialyzed against double-distilled water for three days. The dialyzed reaction solution is freeze-dried to obtain GMHA freeze-dried product.
  • HaCaT cells and sebaceous gland cell culture and collection steps HaCaT cells and sebaceous gland cells are cultured in DMEM complete culture medium in a CO 2 incubator at 37 ⁇ 0.5°C, 5% CO 2 and saturated humidity until HaCaT cells and sebaceous gland cells are Collect cells when the confluence reaches 80%-90%, remove the original culture medium, add 2 mL PBS buffer to rinse twice, add 1.5 mL EDTA-containing trypsin for digestion for 6 to 8 minutes, add 2 mL DMEM complete culture medium to terminate digestion, and centrifuge to collect The cells were washed twice with PBS buffer, and the supernatant was removed, resuspended in PBS buffer, and counted.
  • step (3) The steps and results of microbial growth detection on the stratum corneum established in step (3) are as follows:
  • Propionibacterium acnes is cultured in an anaerobic gas-generating bag at 37°C for 48 hours using enhanced Propionibacterium clostridium liquid culture medium, and the bacterial liquid is taken after culture Centrifuge to remove the supernatant, and resuspend the bacterial solution to a certain concentration.
  • Staphylococcus aureus is cultured in tryptic soybean liquid medium at 37°C for 24 hours. After culture, the bacterial liquid is centrifuged to remove the supernatant, and the bacterial liquid is resuspended to a certain concentration.
  • Staphylococcus epidermidis The bacteria were cultured in LB liquid medium at 37°C for 24 hours. After culture, the bacterial liquid was centrifuged to remove the supernatant, and the bacterial liquid was resuspended to a certain concentration.
  • the cycle threshold (Ct value) calculated by real-time fluorescence quantitative PCR is brought into the pre-established standard curve related to the number of bacteria and the Ct value, and the number of bacteria is calculated; as can be seen from Figures 12, 13, and 14, at different concentrations Acne C After Acidobacterium, Staphylococcus aureus, and Staphylococcus epidermidis are inoculated into the stratum corneum, they can maintain a relatively stable state for a period of time.
  • stratum corneum is available for microbial co-growth and microbial interspecies interactions can be detected.
  • Staphylococcus aureus and Propionibacterium acnes Inoculate Staphylococcus aureus and Propionibacterium acnes at about 1 ⁇ 10 7 CFU/mL and grow them on the model.
  • Separate culture groups for Staphylococcus aureus and Propionibacterium acnes are set up. Staphylococcus aureus and Propionibacterium acnes are cultured together. In the culture group, the number of viable bacteria was measured every 24 hours. It can be seen from Figure 15 that when Staphylococcus aureus and Propionibacterium acnes are co-cultured, Propionibacterium acnes can promote the growth of Staphylococcus aureus, which is consistent with what has been reported in the literature. Propionibacterium acnes produces a small molecule coproporphyrin III that promotes Staphylococcus aureus aggregation and biofilm formation.
  • the present invention establishes a stratum corneum-like layer for the growth of several common skin microorganisms, provides a new model for studying human microorganisms and its production method, and provides a useful method for in vitro evaluation of skin care product efficacy and screening of active ingredient efficacy. and provide new ideas and methods for further research on antibiotic efficacy evaluation.
  • the stratum corneum layer established in Example 2 was used to evaluate the efficacy of cosmetics containing phenoxyethanol or methylparaben.
  • Facial bacteria culture Select Propionibacterium acnes, Staphylococcus aureus, and Staphylococcus epidermidis as facial bacteria; Propionibacterium acnes is cultured in an anaerobic gas-generating bag at 37°C using enhanced Clostridium propionibacterium liquid culture medium. After 48 hours of culture, take the bacterial liquid and centrifuge to remove the supernatant, then re-suspend the bacterial liquid to prepare a certain concentration. Staphylococcus aureus is cultured in tryptic soybean liquid medium at 37°C for 24 hours. After culture, the bacterial liquid is centrifuged to remove the supernatant, and the bacterial liquid is resuspended to a certain concentration.
  • Staphylococcus epidermidis was cultured in LB liquid medium at 37°C for 24 hours. After culture, the bacterial liquid was centrifuged to remove the supernatant, and the bacterial liquid was resuspended to a certain concentration.
  • a total of 5 kinds of lotion samples to be tested were prepared, including the lotion sample without any preservatives, the lotion sample containing methyl paraben with a concentration of 0.1% (NI-0.1), and the lotion sample with a concentration of 0.2
  • Preservatives in cosmetics can alter the balance of the skin microbiota, but the effects of different preservative combinations on the dynamics of the skin's resident flora can be tested through in vitro models, allowing for the correct selection and dosage of preservatives in cosmetic formulations to maintain or restore skin.
  • This embodiment provides a method for constructing a 3D stratum corneum-like model, which includes the following steps:
  • CMA methacrylated collagen
  • CSMA chondroitin sulfate methacrylate
  • GMA glycidyl methacrylate
  • HAMA methacrylated hyaluronic acid
  • Cells were cultured in DMEM complete culture medium at 37 ⁇ 0.5°C, 5% CO2 and saturated humidity in a CO2 incubator. Culture until the cell confluence reaches 80%-90%. Collect the cells, remove the original culture medium, and add PBS. Rinse twice with buffer, add EDTA-containing trypsin for digestion for 6 to 8 minutes, add complete culture medium to terminate digestion, collect cells by centrifugation, rinse twice with PBS buffer, and remove the culture medium.
  • Photocurable gels CMA, GMHA, CSMA, GMA, human primary keratinocytes, human primary sebaceous gland cells, human primary fibroblasts, and human immortalized fibroblasts can also be used in 3D stratum corneum-like models as demonstrated below:
  • Facial bacteria culture Select Propionibacterium acnes, Staphylococcus aureus, and Staphylococcus epidermidis as facial bacteria; Propionibacterium acnes is cultured in an anaerobic gas-generating bag at 37°C for 48 hours using enhanced Clostridium propionibacterium liquid culture medium. Centrifuge the bacterial liquid to remove the supernatant, and resuspend the bacterial liquid to a certain concentration. Staphylococcus aureus is cultured in tryptic soybean liquid medium at 37°C for 24 hours. After culture, the bacterial liquid is centrifuged to remove the supernatant, and the bacterial liquid is resuspended to a certain concentration.
  • Staphylococcus epidermidis was cultured in LB liquid medium at 37°C for 24 hours. After culture, the bacterial liquid was centrifuged to remove the supernatant, and the bacterial liquid was resuspended to a certain concentration.
  • Figure 19 shows a mixture of a certain concentration of CMA or CSMA with human primary keratinocytes, human primary sebaceous gland cells, human primary fibroblasts, human immortalized fibroblasts (HSF cells) and then mixed with Propionibacterium acnes in 96 wells. Bacterial liquid cultured anaerobically in the plate for 48 hours.
  • Figure 20 shows a mixture of a certain concentration of CMA or CSMA with human primary keratinocytes, human primary sebaceous gland cells, human primary fibroblasts, and human immortalized fibroblasts (HSF cells) and then incubated with Staphylococcus epidermidis in a 96-well plate. Bacterial liquid cultured for 24 hours.
  • Example 2 The cuticle-like layer established in Example 2 was used for detection of microbial colonization and biofilm formation:
  • This embodiment provides a method for simulating the composition of microorganisms on the skin surface.
  • This method can obtain a surface microbial composition similar to that of real skin by continuously inoculating facial flora on the stratum corneum layer multiple times, thereby simulating the composition of microorganisms on the skin surface. the goal of.
  • Example 2 the stratum corneum-like layer established in Example 2 was continuously inoculated with facial flora multiple times to simulate the composition of microorganisms on the skin surface:
  • the method of simulating the composition of microorganisms on the skin surface includes the following steps:
  • the bacterial flora obtained from the human face is inoculated onto the model several times in a row, it will form a group similar to the initial flora.
  • the composition of the microbial flora changed after one day of inoculation and culture, but after four days of continuous culture, the 3D cuticle-like model formed a flora composition similar to the initial flora.
  • there is a significant difference between the groups on the 0th day of culture and the first day (anosim test, P ⁇ 0.05).
  • the groups are similar on the 0th day and the fourth day of culture, and there is no significant difference (anosim test, P >0.05).
  • Figure 23 is the result of non-metric multidimensional scaling analysis (NMDS), showing the compositional differences of microbial communities through a two-dimensional ordination diagram. The closer (far) the distance between the two points in Figure 23 is, the smaller (larger) the difference in the microbial communities in the two samples is. It can be seen that the compositional difference in the microbial communities between day0 and day4 is small.
  • NMDS non-metric multidimensional scaling analysis

Abstract

Disclosed are a construction method for a 3D stratum corneum-like model and use thereof. The 3D stratum corneum-like model is composed of a top surface, an intermediate layer, and a bottom surface. The top and bottom surfaces are uneven and are composed of apoptotic cells and/or cell derivatives closely connected to a photocurable gel. The intermediate layer is a photocurable gel, wherein the photocurable gel serves as a scaffold providing a porous structure for the apoptotic cells and/or cell derivatives. The construction method comprises loading a photocurable gel material with apoptotic keratinocytes and/or cell derivatives to form a 3D stratum corneum-like model under light irradiation conditions. The constructed 3D stratum corneum-like model can be effectively used for in vitro evaluation of the efficacy of cosmetics in regulating microecology, testing the antibacterial efficacy of biological preparations such as antibiotics, and has the advantages of low cost, fast construction speed, high stability, and being able to screen for active substances in a high-throughput manner.

Description

一种3D类角质层模型及其构建方法和应用A 3D cuticle-like model and its construction method and application 技术领域Technical field
本发明涉及一种类角质层模型及其构建方法和应用,尤其涉及一种可供多种微生物定殖的3D类角质层模型及其构建方法和应用。The present invention relates to a cuticle-like model and its construction method and application, and in particular to a 3D cuticle-like model that can be colonized by a variety of microorganisms and its construction method and application.
背景技术Background technique
在开发调节微生态类的功效性护肤品的过程中,需要对活性原料或化妆品进行调节微生态的功效评估。以往的实验是通过建立无菌小鼠模型来进行功效评估的,但随着动物实验3R原则的提出和实施,建立合适的体外模型来替代动物模型用于评估化妆品原料或产品在调节微生态方面的应用显得很有必要性,并有巨大的应用性。In the process of developing functional skin care products that regulate microecology, it is necessary to evaluate the efficacy of active ingredients or cosmetics in regulating microecology. In the past, experiments were conducted by establishing germ-free mouse models for efficacy evaluation. However, with the proposal and implementation of the 3R principle of animal experiments, appropriate in vitro models have been established to replace animal models for evaluating the effects of cosmetic raw materials or products on regulating microecology. The application appears to be very necessary and has huge applicability.
皮肤作为人体最大的器官,表面生活着多种不同种类的微生物,有益微生物是防止病原体入侵的物理屏障,可保护身体免受外部侵害。根据人身体不同部位皮肤环境及理化性质的不同,将皮肤生理状态分为三类:湿润的、油脂的和干燥的。虽然皮肤缺乏营养、偏酸、干燥,但其上仍有106个细菌/cm2生活着,大多数细菌定植在角质层的表层部分,以角质细胞的交联蛋白质和脂质为营养来源。As the largest organ of the human body, skin is home to many different types of microorganisms. Beneficial microorganisms serve as a physical barrier to prevent the invasion of pathogens and protect the body from external aggression. According to the different skin environment and physical and chemical properties of different parts of the human body, the physiological state of the skin is divided into three categories: moist, oily and dry. Although the skin lacks nutrition, is acidic, and is dry, there are still 10 6 bacteria/cm 2 living on it. Most of the bacteria colonize the superficial part of the stratum corneum and use the cross-linked proteins and lipids of keratinocytes as a source of nutrition.
使用体外模型研究微生态时,必须考虑从皮肤环境转换为体外模型时对微生物生长及相互作用造成的影响。目前体外研究微生态主要是使用3D表皮模型,通过人原代角质形成细胞分化形成人表皮等效物来构建3D表皮模型,在化妆品行业主要应用于化妆品安全性评价;随着生物打印技术的兴起,使用3D生物打印技术构建新型表皮模型的研究也逐渐增多。通常细菌停留在皮肤表面,共生细菌不会干扰皮肤稳态,当皮肤屏障被破坏,细菌穿过表皮屏障,才会引起炎症反应。有研究人员曾使用健康人足底愈伤组织建立角质层模型,能体现微生物组成员之间的相互作用及接种微生物群的组成和多样性保持相对稳定,但该模型制作原料源于人体组织而难以广泛应用,且无法维持厌氧菌痤疮丙酸杆菌的稳定生长。若使用3D表皮模型应用于化妆品微生态功效评价时耗费时间较长,花费较多,模型批次间的差异较难控制,无法应用于大规模筛选活性物质;因此需要开发和改进一个能模拟皮肤角质层生理状态的供细菌定植的3D类角质层模型。目前建立3D类角质层模型用于评估化妆品原料及成品的调节微生态功效的体外方法还未见相关专利和文献报道。本发明建立的3D类角质层模型可以简单快速的建立,也可以较好地维持人皮肤微生物的组成和多样性。When using in vitro models to study microbiota, the impact on microbial growth and interactions when switching from the skin environment to the in vitro model must be considered. At present, in vitro research on microecology mainly uses 3D epidermal models, which are constructed through the differentiation of human primary keratinocytes into human epidermal equivalents. In the cosmetics industry, they are mainly used for cosmetic safety evaluation; with the rise of bioprinting technology , research on using 3D bioprinting technology to construct new epidermal models is also gradually increasing. Usually bacteria stay on the surface of the skin, and symbiotic bacteria do not interfere with skin homeostasis. When the skin barrier is destroyed, bacteria penetrate the epidermal barrier and cause an inflammatory response. Some researchers have used plantar callus from healthy people to build a stratum corneum model, which can reflect the interaction between microbiome members and keep the composition and diversity of the inoculated microbiome relatively stable. However, the raw materials for making this model are derived from human tissue. It is difficult to apply widely and cannot maintain the stable growth of the anaerobic bacterium Propionibacterium acnes. If the 3D epidermal model is used to evaluate the microecological efficacy of cosmetics, it will take longer and cost more. The differences between model batches are difficult to control, and it cannot be used for large-scale screening of active substances. Therefore, it is necessary to develop and improve a model that can simulate skin. A 3D stratum corneum-like model of the stratum corneum's physiological state for bacterial colonization. Currently, there are no relevant patents or literature reports on the in vitro method of establishing a 3D stratum corneum model to evaluate the microecological regulation efficacy of cosmetic raw materials and finished products. The 3D stratum corneum model established by the present invention can be established simply and quickly, and can also better maintain the composition and diversity of human skin microorganisms.
目前体外评价调节微生态的方法主要是使用3D表皮模型接种微生物当作模型,其方法所用的3D表皮模型是使用人原代角质形成细胞分化形成人表皮等效物,将微生物直接接种到3D表皮模型上用于调节微生态功效评估。 The current method for in vitro evaluation of regulating microecology mainly uses a 3D epidermal model to inoculate microorganisms as a model. The 3D epidermal model used in this method is to use human primary keratinocytes to differentiate to form human epidermal equivalents, and the microorganisms are directly inoculated into the 3D epidermis. The model is used to evaluate the efficacy of regulating microecology.
目前所使用的3D表皮模型价格较高,模型制作时间长,人原代角质形成细胞需分化十几天才能形成3D表皮模型。因此该方法存在成本高,效率低,耗时的问题,难以实现高通量筛选活性成分。The currently used 3D epidermal models are relatively expensive and take a long time to produce. Human primary keratinocytes need to differentiate for more than ten days to form a 3D epidermal model. Therefore, this method has the problems of high cost, low efficiency and time-consuming, and it is difficult to achieve high-throughput screening of active ingredients.
发明内容Contents of the invention
发明目的:本发明的目的是提供一种快速、稳定和可高通量筛选活性物质,并可供多种微生物定殖的3D类角质层模型;本发明的另一目的是提供一种3D类角质层模型的构建方法;本发明的另一目的是提供上述3D类角质层模型在化妆品或其原料功效体外评价、化妆品活性成分功效筛选或生物制剂药效评价中的应用。Purpose of the invention: The purpose of the present invention is to provide a 3D stratum corneum-like model that is fast, stable and capable of high-throughput screening of active substances and can be colonized by a variety of microorganisms; another purpose of the present invention is to provide a 3D stratum corneum-like model. Method for constructing a stratum corneum model; another object of the present invention is to provide the application of the above-mentioned 3D stratum corneum model in in vitro efficacy evaluation of cosmetics or their raw materials, efficacy screening of cosmetic active ingredients, or efficacy evaluation of biological preparations.
技术方案:本发明的一种3D类角质层模型,所述3D类角质层模型包括可光固化凝胶骨架,所述可光固化凝胶骨架负载有凋亡细胞/或细胞衍生物;所述可光固化凝胶骨架由可被照射光引发交联的侧链含有双键的生物大分子构成。Technical solution: a 3D stratum corneum-like model of the present invention, the 3D stratum corneum-like model includes a photocurable gel skeleton, and the photocurable gel skeleton is loaded with apoptotic cells/or cell derivatives; The photocurable gel skeleton is composed of biomacromolecules with double bonds in their side chains that can be cross-linked by irradiation with light.
可选的,凝胶固化时照射光为紫外、蓝光、伽马射线或近红外照射。Optionally, the irradiation light used when the gel is cured is ultraviolet, blue light, gamma ray or near-infrared irradiation.
优选的,所述生物大分子包括GMHA(透明质酸交联甲基丙烯化甘油酯)、CMA(甲基丙烯酸化胶原蛋白)、CSMA(硫酸软骨素甲基丙烯酸酯)、GMA(甲基丙烯酸缩水甘油酯)或HAMA(甲基丙烯酰化透明质酸)中一种或多种。Preferably, the biological macromolecules include GMHA (hyaluronic acid cross-linked glyceryl methacrylate), CMA (methacrylated collagen), CSMA (chondroitin sulfate methacrylate), GMA (methacrylic acid One or more of glycidyl ester) or HAMA (hyaluronic acid methacrylate).
其中,所述3D类角质层模型由顶面、中间层和底面构成,顶面和底面表面凸凹不平,由通过可光固化凝胶紧密连接的凋亡的细胞和/或细胞衍生物构成,中间层以可光固化凝胶为骨架,可光固化凝胶骨架构成若干个孔隙,孔隙内分布有凋亡的细胞和/或细胞衍生物。Wherein, the 3D stratum corneum model is composed of a top surface, a middle layer and a bottom surface. The top and bottom surfaces are uneven and composed of apoptotic cells and/or cell derivatives that are tightly connected through a photo-curable gel. The middle layer The layer uses a photocurable gel as a skeleton, and the photocurable gel skeleton constitutes several pores, and apoptotic cells and/or cell derivatives are distributed in the pores.
进一步地,可光固化凝胶骨架构成的空隙的孔径为1-500μm,优选的,50~150μm。Furthermore, the pore diameter of the voids formed by the photocurable gel skeleton is 1-500 μm, preferably 50-150 μm.
进一步地,所述3D类角质层模型厚度为10μm~1mm。Further, the thickness of the 3D stratum corneum-like model is 10 μm to 1 mm.
进一步地,细胞为皮脂腺细胞和皮肤角质细胞,其中皮脂腺细胞为人原代皮脂腺细胞或人永生化皮脂腺细胞系,角质细胞为人原代角质细胞或人永生化角质形成细胞系;细胞衍生物为细胞碎片和细胞代谢产物。Further, the cells are sebaceous gland cells and skin keratinocytes, wherein the sebaceous gland cells are human primary sebaceous gland cells or human immortalized sebaceous gland cell lines, and the keratinocytes are human primary keratinocytes or human immortalized keratinocyte cell lines; the cell derivatives are cell fragments. and cellular metabolites.
更进一步地,皮肤角质细胞占3D类角质层模型中细胞总量的10%~90%。Furthermore, skin keratinocytes account for 10% to 90% of the total cells in the 3D stratum corneum model.
另一方面,本发明提供一种上述3D类角质层模型的构建方法,包括以下步骤:将可光固化凝胶与凋亡的角质细胞和皮脂腺细胞光固化,即得3D类角质层模型。On the other hand, the present invention provides a method for constructing the above-mentioned 3D stratum corneum-like model, which includes the following steps: light-curing a photocurable gel with apoptotic keratinocytes and sebaceous gland cells to obtain a 3D stratum corneum-like model.
进一步地,所述的光固化方法为5~50mg/mL可光固化凝胶加入0.15%~0.3%的光引发剂,放入孔板中,在光照射的条件下,加入混合均匀的角质细胞和皮脂腺细胞,恒温干燥。Further, the photocuring method is to add 0.15% to 0.3% photoinitiator to 5-50mg/mL photocurable gel, put it into a well plate, and add evenly mixed keratinocytes under the condition of light irradiation. and sebaceous gland cells, dried at constant temperature.
进一步地,所述的光固化方法为0.15%~0.3%的光引发剂与若干数量角质细胞和皮脂腺细胞混合均匀,得到的混合溶液加入到5~50mg/mL GMHA中,放入孔板中,在光 照射的条件下,恒温干燥。Further, the photocuring method is to mix 0.15% to 0.3% photoinitiator with a certain number of keratinocytes and sebaceous gland cells, and the resulting mixed solution is added to 5 to 50 mg/mL GMHA and put into a well plate. in the light Dry at constant temperature under irradiation conditions.
可选的,凝胶固化时照射光为紫外、蓝光、伽马射线或近红外照射。Optionally, the irradiation light used when the gel is cured is ultraviolet, blue light, gamma ray or near-infrared irradiation.
另一方面,本发明提供一种上述3D类角质层模型在化妆品或其原料的体外功效评价、化妆品活性成分的功效筛选或生物制剂的药效评价中的应用。本发明的3D类角质层模型可供多种微生物定殖,可用于评价化妆品和原料在体外调节皮肤微生物组的功效或评价抗生素生物制剂的抑菌功效。On the other hand, the present invention provides an application of the above-mentioned 3D stratum corneum model in in vitro efficacy evaluation of cosmetics or their raw materials, efficacy screening of cosmetic active ingredients, or efficacy evaluation of biological preparations. The 3D stratum corneum model of the present invention can be colonized by a variety of microorganisms and can be used to evaluate the efficacy of cosmetics and raw materials in regulating the skin microbiome in vitro or to evaluate the antibacterial efficacy of antibiotic biological preparations.
进一步地,所述应用的方法,包括以下步骤:Further, the application method includes the following steps:
(1)在3D类角质层模型上接种若干种面部菌模拟面部微生态;面部菌包括但不限于痤疮丙酸杆菌、表皮葡萄球菌、金黄色葡萄球菌、马拉色菌等;(1) Inoculate several kinds of facial bacteria on the 3D stratum corneum model to simulate the facial microecology; facial bacteria include but are not limited to Propionibacterium acnes, Staphylococcus epidermidis, Staphylococcus aureus, Malassezia, etc.;
(2)在已接种面部菌的3D类角质层模型上,涂覆待测试样品;(2) Coat the sample to be tested on the 3D stratum corneum model that has been inoculated with facial bacteria;
(3)一段时间后,检测3D类角质层模型上细菌的数量或菌群每种菌的相对丰度,获得的结果用于评价或筛选测试样品。其中相对丰度是每种菌在菌群中占的比例,代表调节菌群平衡。(3) After a period of time, detect the number of bacteria on the 3D cuticle-like model or the relative abundance of each bacteria in the bacterial community, and the results obtained are used to evaluate or screen the test samples. The relative abundance is the proportion of each type of bacteria in the flora, which represents the adjustment of the balance of the flora.
本发明的类角质层模型基于可光固化水凝胶与凋亡的角质细胞、皮脂腺细胞光固化后形成,并已被证明可供痤疮丙酸杆菌、表皮葡萄球菌、金黄色葡萄球菌共同定殖生长,可应用于评价化妆品调节微生态功效、测试抗生素等生物制剂抑菌功效。其中,可光固化水凝胶的成分为CMA、GMHA、CSMA、GMA或HAMA中一种或多种。The stratum corneum model of the present invention is formed based on photocurable hydrogel and apoptotic keratinocytes and sebaceous gland cells, and has been proven to be co-colonized by Propionibacterium acnes, Staphylococcus epidermidis, and Staphylococcus aureus. Growth can be used to evaluate the efficacy of cosmetics in regulating microecology and test the antibacterial efficacy of biological agents such as antibiotics. Wherein, the component of the photocurable hydrogel is one or more of CMA, GMHA, CSMA, GMA or HAMA.
有益效果:与现有技术相比,本发明具有如下显著优点:使用甲基丙烯酰化的透明质酸水凝胶与凋亡的HaCaT细胞、皮脂腺细胞光固化后形成类似角质层和皮脂腺的结构及可供微生物定殖生长的3D类角质层模型的构建方法。建立的3D类角质层模型可用于体外评价化妆品调节微生态功效、测试抗生素等生物制剂抑菌功效,具有成本低、相对快速、稳定和可高通量筛选活性物质的特点。Beneficial effects: Compared with the existing technology, the present invention has the following significant advantages: it uses methacrylated hyaluronic acid hydrogel and apoptotic HaCaT cells and sebaceous gland cells to form a structure similar to the stratum corneum and sebaceous glands after light curing. and a method for constructing a 3D cuticle-like model for microbial colonization and growth. The established 3D stratum corneum-like model can be used in vitro to evaluate the efficacy of cosmetics in regulating microecology and test the antibacterial efficacy of biological agents such as antibiotics. It has the characteristics of low cost, relatively fast, stable and high-throughput screening of active substances.
附图说明Description of the drawings
图1是本发明的3D类角质层模型的简易图;Figure 1 is a simplified diagram of the 3D stratum corneum-like model of the present invention;
图2是实施例1中GMHA合成方程式;Figure 2 is the GMHA synthesis equation in Example 1;
图3是实施例1中按照方案一制作模型,倒置显微镜放大40倍下模型表面示意图;Figure 3 is a schematic diagram of the surface of the model under 40 times magnification under an inverted microscope when the model was made according to Scheme 1 in Example 1;
图4是实施例1中按照方案二制作模型,倒置显微镜放大20倍下模型表面示意图;Figure 4 is a schematic diagram of the surface of the model under 20 times magnification under an inverted microscope when the model was made according to Scheme 2 in Example 1;
图5是实施例1中按照方案一制作模型,扫描电子显微镜放大500倍下模型表面示意图;Figure 5 is a schematic diagram of the model surface under a scanning electron microscope magnified 500 times in Example 1 according to Scheme 1;
图6是实施例1中按照方案一制作模型,扫描电子显微镜放大1000倍下模型表面示意图;Figure 6 is a schematic diagram of the model surface under a scanning electron microscope magnified 1000 times when the model was made according to Scheme 1 in Example 1;
图7是实施例1中按照方案二制作模型,扫描电子显微镜放大300倍下模型表面示 意图;Figure 7 is a model made according to Scheme 2 in Example 1, and the surface of the model under a scanning electron microscope is magnified 300 times. intention;
图8是实施例1中按照方案二制作模型,扫描电子显微镜放大5000倍下模型横截面孔径示意图;Figure 8 is a schematic diagram of the cross-sectional aperture of the model produced according to Scheme 2 in Example 1 and magnified 5000 times under a scanning electron microscope;
图9是实施例2中将1×106CFU左右的痤疮丙酸杆菌接种到模型上,在35℃生化培养箱培养,分别在培养第0天、2天、3天、4天、5天检测细菌的数目折线图;Figure 9 shows that in Example 2, about 1×10 6 CFU of Propionibacterium acnes was inoculated into the model and cultured in a 35°C biochemical incubator. On the 0th, 2nd, 3rd, 4th and 5th days of culture respectively Line chart of the number of detected bacteria;
图10是实施例2中类角质层模型在扫描电镜400倍下看到细胞间由GMHA交联形成致密的类角质层;Figure 10 shows the stratum corneum model in Example 2. Under a scanning electron microscope at 400 times, it is seen that the cells are cross-linked by GMHA to form a dense stratum corneum;
图11是图10局部放大图,面部常见的厌氧菌痤疮丙酸杆菌在类角质层表面建立生物膜示意图;Figure 11 is a partial enlarged view of Figure 10, showing a schematic diagram of the establishment of a biofilm on the surface of the stratum corneum by Propionibacterium acnes, a common anaerobic bacterium on the face;
图12是实施例2中将105~108CFU的痤疮丙酸杆菌接种到模型上培养,在第1,3,5,7,9天检测细菌总数;Figure 12 shows that in Example 2, 10 5 to 10 8 CFU of Propionibacterium acnes was inoculated into the model and cultured, and the total number of bacteria was detected on days 1, 3, 5, 7, and 9;
图13是实施例2中将105~108CFU的表皮葡萄球菌接种到模型上培养,在第1,3,5,7,9天检测细菌总数;Figure 13 shows that in Example 2, 10 5 to 10 8 CFU of Staphylococcus epidermidis was inoculated into the model and cultured, and the total number of bacteria was detected on days 1, 3, 5, 7, and 9;
图14是实施例2中将105~108CFU的金黄色葡萄球菌接种到模型上培养,在第1,3,5,7,9天检测细菌总数;Figure 14 shows that in Example 2, 10 5 to 10 8 CFU of Staphylococcus aureus was inoculated into the model and cultured, and the total number of bacteria was detected on days 1, 3, 5, 7, and 9;
图15是实施例2中将1×107CFU/mL左右的金黄色葡萄球菌和痤疮丙酸杆菌接种在模型上培养,在第1,2,3,4,6天检测细菌总数;Figure 15 shows that in Example 2, about 1×10 7 CFU/mL of Staphylococcus aureus and Propionibacterium acnes were inoculated and cultured on the model, and the total number of bacteria was detected on days 1, 2, 3, 4, and 6;
图16是以痤疮丙酸杆菌、金黄色葡萄球菌、表皮葡萄球菌共同培养建立的面部微生态添加不同化妆水样品后三种细菌的数目,其中0组为无防腐剂的化妆水组;NI-0.1组为含0.1%羟苯甲酯的化妆水组;NI-0.2组为含0.2%羟苯甲酯的化妆水组;BEN-0.6组为含0.6%苯氧乙醇的化妆水组;BEN-0.8组为含0.8%苯氧乙醇的化妆水组。Figure 16 shows the number of three types of bacteria after adding different lotion samples to the facial microecology established by co-culture of Propionibacterium acnes, Staphylococcus aureus, and Staphylococcus epidermidis. Group 0 is the preservative-free lotion group; NI- The 0.1 group is a lotion group containing 0.1% methylparaben; the NI-0.2 group is a lotion group containing 0.2% methylparaben; the BEN-0.6 group is a lotion group containing 0.6% phenoxyethanol; BEN- Group 0.8 is a lotion group containing 0.8% phenoxyethanol.
图17是CMA凝胶和光引发剂混合,在紫外灯照射后,形成固化的凝胶;Figure 17 shows a mixture of CMA gel and photoinitiator, which forms a solidified gel after being irradiated with UV light;
图18是CSMA凝胶和光引发剂混合,在紫外灯照射后,形成固化的凝胶;Figure 18 shows a mixture of CSMA gel and photoinitiator, which forms a solidified gel after being irradiated with UV light;
图19是将一定浓度的CMA或CSMA与人原代角质层细胞、人原代皮脂腺细胞、人原代成纤维细胞、人永生化成纤维细胞(HSF细胞)混合后与痤疮丙酸杆菌在96孔板中厌氧培养48h的菌液图;(A)是将一定浓度的CMA或CSMA与人原代角质层细胞、人原代皮脂腺细胞、人原代成纤维细胞、人永生化成纤维细胞(HSF细胞)混合后与痤疮丙酸杆菌在96孔板中厌氧培养48h的菌液图;(B)是培养后痤疮丙酸杆菌悬液吸光度柱状图;Figure 19 shows a mixture of a certain concentration of CMA or CSMA with human primary keratinocytes, human primary sebaceous gland cells, human primary fibroblasts, and human immortalized fibroblasts (HSF cells) and then mixed with Propionibacterium acnes in 96 wells. Picture of the bacteria cultured in the plate anaerobically for 48 hours; (A) is a mixture of a certain concentration of CMA or CSMA and human primary keratinocytes, human primary sebaceous gland cells, human primary fibroblasts, and human immortalized fibroblasts (HSF). Cells) were mixed with P. acnes and cultured anaerobically in a 96-well plate for 48 hours; (B) is a histogram of the absorbance of the P. acnes suspension after culture;
图20是将一定浓度的CMA或CSMA与人原代角质层细胞、人原代皮脂腺细胞、人原代成纤维细胞、人永生化成纤维细胞(HSF细胞)混合后与表皮葡萄球菌在96孔板中培养24h的菌液图;(A)是将一定浓度的CMA或CSMA与人原代角质层细胞、 人原代皮脂腺细胞、人原代成纤维细胞、人永生化成纤维细胞(HSF细胞)混合后与表皮葡萄球菌在96孔板中培养24h的菌液图;(B)是培养后表皮葡萄球菌悬液吸光度柱状图;Figure 20 shows a mixture of a certain concentration of CMA or CSMA with human primary keratinocytes, human primary sebaceous gland cells, human primary fibroblasts, and human immortalized fibroblasts (HSF cells), and then mixed with Staphylococcus epidermidis in a 96-well plate. Diagram of bacterial liquid cultured for 24 hours; (A) is a mixture of a certain concentration of CMA or CSMA and human primary keratinocytes, Human primary sebaceous gland cells, human primary fibroblasts, and human immortalized fibroblasts (HSF cells) were mixed and cultured with Staphylococcus epidermidis in a 96-well plate for 24 hours; (B) is the suspension of Staphylococcus epidermidis after culture. Liquid absorbance histogram;
图21是马拉色菌在模型上的生长情况图。Figure 21 is a diagram of the growth of Malassezia on the model.
图22是培养第0天、第1天、第4天三组的组间差异图,图中分别展示第0天组内样本间距离的分布箱线图以及第0天样本与第1天或第4天的样本间距离的箱线图。箱线图中,各符号含义如下:箱的上下端线,上下四分位数(Interquartile range,IQR);中位线,中位数;上下边缘,最大值和最小值(1.5倍的IQR范围之内的极值);在上下边缘的外部的点,表示异常值。Figure 22 is a graph of the differences between the three groups on days 0, 1, and 4 of culture. The figure shows the distribution box plot of the distance between samples in the group on day 0 and the difference between the sample on day 0 and the sample on day 1 or 4. Box plot of distances between samples on day 4. In the box plot, the meanings of each symbol are as follows: the upper and lower end lines of the box, the upper and lower interquartile range (IQR); the median line, the median; the upper and lower edges, the maximum and minimum values (1.5 times the IQR range). extreme values within); points outside the upper and lower edges represent outliers.
图23是NMDS分析图,图中每个点代表一个样本,不同形状的点指示不同的样本(组)。NMDS采用等级排序,可近似认为两点之间的距离越近(远),表明两个样本中微生物群落的差异越小(大)。椭圆形虚线圈为95%置信椭圆(即该样本组100个样本中会有95个落在其中)。Figure 23 is an NMDS analysis diagram. Each point in the diagram represents a sample, and points of different shapes indicate different samples (groups). NMDS adopts hierarchical sorting, which can be approximated to mean that the closer (far) the distance between two points is, the smaller (larger) the difference in the microbial communities in the two samples is. The elliptical dotted circle is the 95% confidence ellipse (that is, 95 out of 100 samples of this sample group will fall within it).
图24是培养第0天、第1天和第4天三组菌群的属水平相对丰度排名前二十的物种组成柱状图。图中横坐标为各分组的名称,纵坐标为属水平下各分类单元的相对丰度。Figure 24 is a histogram of the top twenty species compositions at the genus level relative abundance of the three groups of bacterial groups on days 0, 1 and 4 of culture. The abscissa in the figure is the name of each group, and the ordinate is the relative abundance of each taxon at the genus level.
具体实施方式Detailed ways
下面结合附图对本发明的技术方案作进一步说明。The technical solution of the present invention will be further described below with reference to the accompanying drawings.
在一实施例中提供一种3D类角质层模型,如图1所示,所述3D类角质层模型由顶面1、中间层2和底面3构成,顶面1和底面3表面凸凹不平,由通过可光固化凝胶紧密连接的凋亡的细胞和/或细胞衍生物构成,中间层以可光固化凝胶为骨架5,可光固化凝胶的骨架5构成若干个空隙,空隙内分布细胞4,细胞4为凋亡的细胞和/或细胞衍生物;细胞4在可光固化凝胶的骨架5内紧密排列,形成一定的密闭空间,可供厌氧菌生长;可光固化凝胶的骨架5构成的空隙的孔径为1~500μm,优选为50~150μm;中间层2厚度为10μm~1mm。In one embodiment, a 3D stratum corneum-like model is provided. As shown in Figure 1, the 3D stratum corneum-like model is composed of a top surface 1, a middle layer 2 and a bottom surface 3. The surfaces of the top surface 1 and the bottom surface 3 are uneven. It is composed of apoptotic cells and/or cell derivatives that are tightly connected through a photo-curable gel. The middle layer uses the photo-curable gel as a skeleton 5. The skeleton 5 of the photo-curable gel forms a number of gaps distributed within the gaps. Cells 4, cells 4 are apoptotic cells and/or cell derivatives; cells 4 are closely arranged within the skeleton 5 of the photocurable gel, forming a certain closed space for the growth of anaerobic bacteria; the photocurable gel The pore diameter of the voids formed by the skeleton 5 is 1 to 500 μm, preferably 50 to 150 μm; the thickness of the intermediate layer 2 is 10 μm to 1 mm.
其中,可光固化凝胶骨架由可被照射光引发交联的侧链含有双键的生物大分子构成,可被照射光引发交联的侧链含有双键的生物大分子制成的凝胶均可实现本发明目的。优选的,所述生物大分子为GMHA、CMA、CSMA、GMA或HAMA。Among them, the photocurable gel skeleton is composed of biological macromolecules whose side chains contain double bonds that can be cross-linked by irradiation of light. All can achieve the purpose of the present invention. Preferably, the biological macromolecule is GMHA, CMA, CSMA, GMA or HAMA.
可选的,凝胶固化时照射光为紫外、蓝光、伽马射线或近红外照射。Optionally, the irradiation light used when the gel is cured is ultraviolet, blue light, gamma ray or near-infrared irradiation.
细胞优选为皮脂腺细胞和HaCaT细胞。HaCaT细胞占3D类角质层模型中细胞总量的10~90%。The cells are preferably sebaceous gland cells and HaCaT cells. HaCaT cells account for 10-90% of the total cells in the 3D stratum corneum model.
在一实施例中提供一种3D类角质层模型的构建方法,将GMHA与HaCaT细胞和皮脂腺细胞光固化,即得3D类角质层模型。 In one embodiment, a method for constructing a 3D stratum corneum-like model is provided. GMHA, HaCaT cells and sebaceous gland cells are photocured to obtain a 3D stratum corneum-like model.
在一实施例中提供一种3D类角质层模型在化妆品或其原料功效体外评价、化妆品活性成分功效筛选或生物制剂药效评价中的应用。其中所述应用的方法,包括以下步骤:In one embodiment, the application of a 3D stratum corneum model in in vitro efficacy evaluation of cosmetics or their raw materials, efficacy screening of cosmetic active ingredients, or efficacy evaluation of biological preparations is provided. The application method described therein includes the following steps:
(1)在3D类角质层模型上接种若干种面部菌模拟面部微生态;(1) Inoculate several kinds of facial bacteria on the 3D stratum corneum model to simulate the facial microecology;
(2)在已接种面部菌的3D类角质层模型上,涂覆待测试样品;(2) Coat the sample to be tested on the 3D stratum corneum model that has been inoculated with facial bacteria;
(3)一段时间后,检测3D类角质层模型上细菌的数量或菌群每种菌的相对丰度,获得的结果用于评价或筛选测试样品。(3) After a period of time, detect the number of bacteria on the 3D cuticle-like model or the relative abundance of each bacteria in the bacterial community, and the results obtained are used to evaluate or screen the test samples.
面部菌包括但不限于痤疮丙酸杆菌、表皮葡萄球菌、金黄色葡萄球菌、马拉色菌等。Facial bacteria include, but are not limited to, Propionibacterium acnes, Staphylococcus epidermidis, Staphylococcus aureus, Malassezia, etc.
HaCaT细胞是指人永生化角质形成细胞,是非肿瘤来源的人正常皮肤永生化角质形成细胞株,与正常人角质形成细胞分化特性相似。HaCaT cells refer to human immortalized keratinocytes, which are immortalized keratinocytes derived from non-tumor human normal skin and have similar differentiation characteristics to normal human keratinocytes.
融合达到80%是指在培养皿上培养时,贴壁细胞单层覆盖培养皿上表面80%的面积。Reaching 80% confluence means that when cultured on a culture dish, the adherent cell monolayer covers 80% of the upper surface of the culture dish.
PMA-qPCR定量检测是指使用叠氮溴化丙啶(PMA)与死细胞的DNA牢固结合,PCR反应时与PMA结合后的DNA不会扩增。所以,PMA结合实时定量PCR(PMA-qPCR)可以排除死细胞的干扰,只对活细胞的DNA进行定量。PMA-qPCR quantitative detection uses propidium bromide azide (PMA) to bind firmly to the DNA of dead cells. The DNA combined with PMA will not amplify during the PCR reaction. Therefore, PMA combined with real-time quantitative PCR (PMA-qPCR) can eliminate the interference of dead cells and only quantify the DNA of living cells.
GMHA是指甲基丙烯酰化的透明质酸交联形成的水凝胶。GMHA is a hydrogel formed by cross-linking methacrylated hyaluronic acid.
实施例1Example 1
本实施例提供一种3D类角质层模型的构建方法,包括以下步骤:This embodiment provides a method for constructing a 3D stratum corneum-like model, which includes the following steps:
(1)HaCaT细胞、皮脂腺细胞培养步骤:HaCaT细胞、皮脂腺细胞用DMEM完全培养液于37±0.5℃、5%CO2及饱和湿度的CO2培养箱内培养,培养至HaCaT细胞、皮脂腺细胞融合度达到80%-90%进行收集细胞,除去原培养基,加入PBS缓冲液润洗两遍,加入含EDTA胰蛋白酶消化6~8min,加入完全培养基终止消化,离心收集细胞,用PBS缓冲液润洗两遍,除去培养基。(1) HaCaT cells and sebaceous gland cell culture steps: HaCaT cells and sebaceous gland cells are cultured in DMEM complete culture medium in a CO 2 incubator at 37±0.5°C, 5% CO 2 and saturated humidity until HaCaT cells and sebaceous gland cells fuse. Collect cells when the concentration reaches 80%-90%, remove the original culture medium, add PBS buffer to rinse twice, add EDTA-containing trypsin for digestion for 6 to 8 minutes, add complete culture medium to terminate digestion, centrifuge to collect cells, and rinse with PBS buffer Rinse twice and remove culture medium.
(2)透明质酸交联甲基丙烯化甘油酯(GMHA)水凝胶合成:如图2所示,取1g透明质酸(分子量4.1×105Da)溶解于100mL PBS缓冲液,向透明质酸溶液中依次加入7.5mL三乙胺,7.5g四丁基溴化铵,7.5mL甲基丙烯化缩水甘油酯。其中,三乙胺为催化剂,四丁基溴化铵为相转移催化剂。设定反应温度为20℃,不断搅拌下反应44小时。反应结束后,将反应液转移到透析袋(截留量3.5×103Da)中,双蒸水透析三天,每12小时换一次双蒸水。透析后的反应液经冷冻干燥,得到GMHA冻干品。(2) Synthesis of hyaluronic acid cross-linked glyceryl methacrylate (GMHA) hydrogel: As shown in Figure 2, take 1g of hyaluronic acid (molecular weight 4.1×10 5 Da) and dissolve it in 100 mL of PBS buffer. Add 7.5 mL triethylamine, 7.5 g tetrabutylammonium bromide, and 7.5 mL glycidyl methacrylate in sequence to the acid solution. Among them, triethylamine is the catalyst and tetrabutylammonium bromide is the phase transfer catalyst. Set the reaction temperature to 20°C and react for 44 hours with constant stirring. After the reaction, the reaction solution was transferred to a dialysis bag (cutoff 3.5×10 3 Da) and dialyzed with double-distilled water for three days, changing the double-distilled water every 12 hours. The dialyzed reaction solution is freeze-dried to obtain GMHA freeze-dried product.
(3)类角质层建立步骤:方案一:取100μL 5~20mg/mL GMHA加入0.15%~0.3%的LAP,放入24孔板中,在紫外灯下照射5~15min,加入混合均匀的6×105个HaCaT细胞和6×104个皮脂腺细胞,放入37℃恒温干燥24~48h。 (3) Steps for establishing stratum corneum: Plan 1: Take 100 μL of 5-20 mg/mL GMHA and add 0.15%-0.3% LAP, put it into a 24-well plate, irradiate it under a UV lamp for 5-15 minutes, and add evenly mixed 6 ×10 5 HaCaT cells and 6 × 10 4 sebaceous gland cells were dried at 37°C for 24 to 48 hours.
得到的3D类角质层模型如图3、5、7所示。The obtained 3D stratum corneum-like model is shown in Figures 3, 5, and 7.
方案二:取100μL 5~20mg/mL GMHA,向其中加入含有0.15%~0.3%的LAP、6×105个HaCaT细胞和6×104个皮脂腺细胞混匀液,放入24孔板中,在紫外灯下照射5~15min,放入37℃恒温干燥24~48h。Option 2: Take 100 μL of 5-20 mg/mL GMHA, add a mixture containing 0.15%-0.3% LAP, 6×10 5 HaCaT cells and 6×10 4 sebaceous gland cells, and place it into a 24-well plate. Irradiate under ultraviolet lamp for 5 to 15 minutes and dry at 37°C for 24 to 48 hours.
得到的3D类角质层模型如图4、6、8所示。The obtained 3D stratum corneum-like model is shown in Figures 4, 6, and 8.
上述方法均将形成一层复合材料,含有大量的角质形成细胞,GMHA凝胶将细胞及细胞衍生物紧密连接,形成紧密的类角质层,厚度10μm~1mm,表面凸凹不平,凝胶具有50~150μm孔径,细胞可在孔径内紧密排列,形成致密的可在内部形成一定的密闭空间,该模型可为皮肤上厌氧菌和需氧菌分别提供适合的生长环境,微生物在模型上可以共生长。The above methods will form a layer of composite material containing a large number of keratinocytes. The GMHA gel closely connects the cells and cell derivatives to form a tight keratin-like layer with a thickness of 10 μm ~ 1 mm and an uneven surface. The gel has a thickness of 50 ~ With a pore size of 150 μm, cells can be closely arranged within the pore to form a dense and certain closed space inside. This model can provide a suitable growth environment for anaerobic bacteria and aerobic bacteria on the skin, and microorganisms can grow together on the model. .
实施例2Example 2
本实施例提供的3D类角质层模型的构建方法,包括以下步骤:The method for constructing a 3D stratum corneum-like model provided in this embodiment includes the following steps:
(1)GMHA合成:取1g透明质酸溶解于100mL PBS缓冲液,向透明质酸溶液中依次加入7.5mL三乙胺,7.5g四丁基溴化铵,7.5mL甲基丙烯化缩水甘油酯。其中,三乙胺为催化剂,四丁基溴化铵为相转移催化剂。设定反应温度为20℃,不断搅拌下反应30~40小时。反应结束后,将反应液转移到透析袋(截留量3.5×103Da)中,双蒸水透析三天。透析后的反应液经冷冻干燥,得到GMHA冻干品。(1) GMHA synthesis: Dissolve 1g hyaluronic acid in 100mL PBS buffer, add 7.5mL triethylamine, 7.5g tetrabutylammonium bromide, and 7.5mL glycidyl methacrylate to the hyaluronic acid solution in sequence . Among them, triethylamine is the catalyst and tetrabutylammonium bromide is the phase transfer catalyst. Set the reaction temperature to 20°C and react for 30 to 40 hours with constant stirring. After the reaction, the reaction solution was transferred to a dialysis bag (cutoff 3.5×10 3 Da) and dialyzed against double-distilled water for three days. The dialyzed reaction solution is freeze-dried to obtain GMHA freeze-dried product.
(2)HaCaT细胞、皮脂腺细胞培养收集步骤:HaCaT细胞、皮脂腺细胞用DMEM完全培养液于37±0.5℃、5%CO2及饱和湿度的CO2培养箱内培养,培养至HaCaT细胞、皮脂腺细胞融合度达到80%-90%进行收集细胞,除去原培养基,加入2mL PBS缓冲液润洗两遍,加入1.5mL含EDTA胰蛋白酶消化6~8min,加入2mL DMEM完全培养基终止消化,离心收集细胞,用PBS缓冲液润洗两遍,去除上清液后,用PBS缓冲液重新混悬并计数。(2) HaCaT cells and sebaceous gland cell culture and collection steps: HaCaT cells and sebaceous gland cells are cultured in DMEM complete culture medium in a CO 2 incubator at 37±0.5°C, 5% CO 2 and saturated humidity until HaCaT cells and sebaceous gland cells are Collect cells when the confluence reaches 80%-90%, remove the original culture medium, add 2 mL PBS buffer to rinse twice, add 1.5 mL EDTA-containing trypsin for digestion for 6 to 8 minutes, add 2 mL DMEM complete culture medium to terminate digestion, and centrifuge to collect The cells were washed twice with PBS buffer, and the supernatant was removed, resuspended in PBS buffer, and counted.
(3)建立类角质层模型:取100μL 5mg/mL GMHA并加入0.15mg LAP,避光混匀后放入含有1mL1.5%琼脂的24孔板孔中,在405nm紫外灯下照射5~15min,固化后再加入混合均匀的大约6×105个HaCaT细胞和6×104个皮脂腺细胞,放入37℃生化培养箱干燥12~48h。(3) Establish a stratum corneum model: Take 100 μL of 5 mg/mL GMHA and add 0.15 mg of LAP, mix well in the dark, then place it into a 24-well plate containing 1 mL of 1.5% agar, and irradiate it under a 405 nm UV lamp for 5 to 15 minutes. , after solidification, add approximately 6×10 5 HaCaT cells and 6×10 4 sebaceous gland cells that are evenly mixed, and place them in a 37°C biochemical incubator to dry for 12 to 48 hours.
对步骤(3)建立的类角质层作微生物生长检测步骤及结果如下:The steps and results of microbial growth detection on the stratum corneum established in step (3) are as follows:
(1)痤疮丙酸杆菌、金黄色葡萄球菌、表皮葡萄球菌培养步骤:痤疮丙酸杆菌使用增强梭状丙酸杆菌液体培养基在厌氧产气袋中37℃培养48h,培养后取菌液离心去上清,重新混悬配置成一定的浓度的菌液。金黄色葡萄球菌使用胰酪大豆胨液体培养基37℃培养24h,培养后取菌液离心去上清,重新混悬配置成一定的浓度的菌液。表皮葡萄球 菌使用LB液体培养基37℃培养24h,培养后取菌液离心去上清,重新混悬配置成一定的浓度的菌液。(1) Culture steps for Propionibacterium acnes, Staphylococcus aureus, and Staphylococcus epidermidis: Propionibacterium acnes is cultured in an anaerobic gas-generating bag at 37°C for 48 hours using enhanced Propionibacterium clostridium liquid culture medium, and the bacterial liquid is taken after culture Centrifuge to remove the supernatant, and resuspend the bacterial solution to a certain concentration. Staphylococcus aureus is cultured in tryptic soybean liquid medium at 37°C for 24 hours. After culture, the bacterial liquid is centrifuged to remove the supernatant, and the bacterial liquid is resuspended to a certain concentration. Staphylococcus epidermidis The bacteria were cultured in LB liquid medium at 37°C for 24 hours. After culture, the bacterial liquid was centrifuged to remove the supernatant, and the bacterial liquid was resuspended to a certain concentration.
(2)平板计数法检测细菌在类角质层上是否能存活:(2) Plate counting method to detect whether bacteria can survive on the stratum corneum:
将1×106CFU左右的痤疮丙酸杆菌接种到模型上,在35℃生化培养箱培养,分别在培养第0天、2天、3天、4天、5天检测细菌数目。具体操作方法为将模型用刀切碎,放入15mL离心管中,加入6mL PBS缓冲液,涡旋30min洗脱分离出细菌。将菌液用PBS混悬,稀释数个倍数,分别涂布到培养基平板上,厌氧培养48h,对平板上长出的菌落数计数,根据平板计数法计算出菌液的数目。通过图9可以看出痤疮丙酸杆菌能在类角质层上存活,并能在一定范围内维持稳态。About 1×10 6 CFU of Propionibacterium acnes was inoculated into the model, cultured in a 35°C biochemical incubator, and the number of bacteria was detected on days 0, 2, 3, 4, and 5 of culture. The specific operation method is to chop the model into pieces with a knife, put it into a 15mL centrifuge tube, add 6mL PBS buffer, and vortex for 30 minutes to elute and isolate the bacteria. Suspend the bacterial liquid with PBS, dilute it several times, spread it on the culture medium plate, and incubate anaerobically for 48 hours. Count the number of bacterial colonies growing on the plate, and calculate the number of bacterial liquid according to the plate counting method. It can be seen from Figure 9 that P. acnes can survive on the stratum corneum and maintain a steady state within a certain range.
(3)类角质层微生物定殖形成生物膜检测:(3) Detection of colonization and formation of biofilm by cuticle-like microorganisms:
使用上述2.3中制成的类角质层,接种约1×107CFU左右的痤疮丙酸杆菌35℃培养48h。培养后,冷冻干燥机冻干,使用扫描电子显微镜拍摄微生物定殖在类角质层上的图像。结果如图10所示在400倍下的类角质层模型可以清楚的看到细胞间由GMHA交联形成致密的类角质层。图11为图10局部放大图,痤疮丙酸杆菌在类角质层表面建立生物膜,定殖生长。Use the stratum corneum prepared in 2.3 above and inoculate it with about 1×10 7 CFU of Propionibacterium acnes and culture it at 35°C for 48 hours. After culture, they were lyophilized in a freeze dryer and images of the microorganisms colonizing the cuticle were taken using a scanning electron microscope. The results are shown in Figure 10. In the cuticle model at 400 times, it can be clearly seen that the cells are cross-linked by GMHA to form a dense cuticle. Figure 11 is a partial enlarged view of Figure 10. Propionibacterium acnes establishes a biofilm on the surface of the stratum corneum and colonizes and grows.
(4)PMA-qPCR定量检测类角质层上微生物生长情况:(4) PMA-qPCR quantitative detection of microbial growth on the stratum corneum:
将不同浓度的痤疮丙酸杆菌、金黄色葡萄球菌、表皮葡萄球菌分别接种到模型上,在35℃生化培养箱培养,分别在培养第0天、1天、3天、5天、9天检测细菌的数目。将模型用刀切碎,放入15mL离心管中,加入6mL PBS缓冲液,涡旋30min洗脱分离出细菌。加入490μL PBS重悬细菌,加入10μL 100μg/mL的PMA溶液,避光混匀后常温孵育10min,500W钨光灯光照10min。使用Bacteria DNA isolation Mini Kit试剂盒按照说明书方法提取细菌DNA,使用ChamQ SYBR qPCR Master MiX和表1中细菌的16SrRNA特异性引物序列,进行q-PCR检测。Different concentrations of Propionibacterium acnes, Staphylococcus aureus, and Staphylococcus epidermidis were inoculated into the model, cultured in a 35°C biochemical incubator, and detected on days 0, 1, 3, 5, and 9 of culture respectively. Number of bacteria. Chop the model into pieces with a knife, put it into a 15mL centrifuge tube, add 6mL PBS buffer, and vortex for 30 minutes to elute and isolate the bacteria. Add 490 μL of PBS to resuspend the bacteria, add 10 μL of 100 μg/mL PMA solution, mix well in the dark, and incubate at room temperature for 10 min. Illuminate with a 500W tungsten light for 10 min. Use the Bacteria DNA isolation Mini Kit to extract bacterial DNA according to the instructions, and use ChamQ SYBR qPCR Master MiX and the bacterial 16SrRNA-specific primer sequence in Table 1 to perform q-PCR detection.
表1
Table 1
将实时荧光定量PCR计算的循环阈值(Ct值)带入到事先建立的细菌数目与Ct值相关的标准曲线,计算出细菌的数目;由图12、13、14可以看出,在不同浓度的痤疮丙 酸杆菌、金黄色葡萄球菌、表皮葡萄球菌接种到类角质层上后,在一段时间内能维持相对稳定的状态。The cycle threshold (Ct value) calculated by real-time fluorescence quantitative PCR is brought into the pre-established standard curve related to the number of bacteria and the Ct value, and the number of bacteria is calculated; as can be seen from Figures 12, 13, and 14, at different concentrations Acne C After Acidobacterium, Staphylococcus aureus, and Staphylococcus epidermidis are inoculated into the stratum corneum, they can maintain a relatively stable state for a period of time.
在类角质层上可供微生物共同生长并能检测到微生物种间相互作用。The stratum corneum is available for microbial co-growth and microbial interspecies interactions can be detected.
将1×107CFU/mL左右的金黄色葡萄球菌和痤疮丙酸杆菌接种在模型上生长,分别设置金黄色葡萄球菌和痤疮丙酸杆菌单独培养组,金黄色葡萄球菌和痤疮丙酸杆菌共同培养组,每隔24h检测一次活细菌的数量,从图15可以看出金黄色葡萄球菌和痤疮丙酸杆菌共同培养时,痤疮丙酸杆菌能促进金黄色葡萄球菌的生长,与文献中报道的痤疮丙酸杆菌产生一种小分子粪卟啉III,可促进金黄色葡萄球菌聚集和生物膜形成相符合。Inoculate Staphylococcus aureus and Propionibacterium acnes at about 1×10 7 CFU/mL and grow them on the model. Separate culture groups for Staphylococcus aureus and Propionibacterium acnes are set up. Staphylococcus aureus and Propionibacterium acnes are cultured together. In the culture group, the number of viable bacteria was measured every 24 hours. It can be seen from Figure 15 that when Staphylococcus aureus and Propionibacterium acnes are co-cultured, Propionibacterium acnes can promote the growth of Staphylococcus aureus, which is consistent with what has been reported in the literature. Propionibacterium acnes produces a small molecule coproporphyrin III that promotes Staphylococcus aureus aggregation and biofilm formation.
综上所述本发明建立一个类角质层,可供几种常见的皮肤微生物生长,提供一种新的用于研究人体微生物的模型及其制作方法,为护肤品功效体外评价、活性成分功效筛选及抗生素药效评价的进一步研究提供新的思路和方法。In summary, the present invention establishes a stratum corneum-like layer for the growth of several common skin microorganisms, provides a new model for studying human microorganisms and its production method, and provides a useful method for in vitro evaluation of skin care product efficacy and screening of active ingredient efficacy. and provide new ideas and methods for further research on antibiotic efficacy evaluation.
实施例3Example 3
将实施例2中建立的类角质层用于评价含有苯氧乙醇或羟苯甲酯的化妆品的功效。The stratum corneum layer established in Example 2 was used to evaluate the efficacy of cosmetics containing phenoxyethanol or methylparaben.
具体步骤如下:对几种面部菌的影响步骤及结果如下:The specific steps are as follows: The steps and results of influencing several facial bacteria are as follows:
(1)面部菌培养培养:选择痤疮丙酸杆菌、金黄色葡萄球菌、表皮葡萄球菌作为面部菌;痤疮丙酸杆菌使用增强梭状丙酸杆菌液体培养基在厌氧产气袋中37℃培养48h,培养后取菌液离心去上清,重新混悬配置成一定的浓度的菌液。金黄色葡萄球菌使用胰酪大豆胨液体培养基37℃培养24h,培养后取菌液离心去上清,重新混悬配置成一定的浓度的菌液。表皮葡萄球菌使用LB液体培养基37℃培养24h,培养后取菌液离心去上清,重新混悬配置成一定的浓度的菌液。(1) Facial bacteria culture: Select Propionibacterium acnes, Staphylococcus aureus, and Staphylococcus epidermidis as facial bacteria; Propionibacterium acnes is cultured in an anaerobic gas-generating bag at 37°C using enhanced Clostridium propionibacterium liquid culture medium. After 48 hours of culture, take the bacterial liquid and centrifuge to remove the supernatant, then re-suspend the bacterial liquid to prepare a certain concentration. Staphylococcus aureus is cultured in tryptic soybean liquid medium at 37°C for 24 hours. After culture, the bacterial liquid is centrifuged to remove the supernatant, and the bacterial liquid is resuspended to a certain concentration. Staphylococcus epidermidis was cultured in LB liquid medium at 37°C for 24 hours. After culture, the bacterial liquid was centrifuged to remove the supernatant, and the bacterial liquid was resuspended to a certain concentration.
(2)配置待测化妆水样品:(2) Configure the lotion sample to be tested:
按照表2中配方,称量A2、A3、A4及A5相,加入适量去离子水,50~60℃水浴使其充分溶解。称量B2、B3、B4及各浓度防腐剂,50~60℃水浴,充分溶解后加入B1相,混匀。将A相与B相混合,充分混匀后测量pH值,加入适量柠檬酸钠至pH 5~6。补充去离子水至100%。按照表3添加防腐剂及浓度。According to the formula in Table 2, weigh the A2 , A3 , A4 and A5 phases, add an appropriate amount of deionized water, and fully dissolve them in a 50-60°C water bath. Weigh B 2 , B 3 , B 4 and preservatives of various concentrations, put them in a 50-60°C water bath, add phase B 1 after they are fully dissolved, and mix well. Mix phase A and phase B, mix thoroughly, then measure the pH value, and add an appropriate amount of sodium citrate to pH 5-6. Add deionized water to 100%. Add preservatives and concentrations according to Table 3.
表2

Table 2

表3
table 3
通过以上方法,共配置5种待测化妆水样品,分别为未包含任何防腐剂的化妆水样品,含有浓度为0.1%的羟苯甲酯的化妆水样品(NI-0.1),含有浓度为0.2%的羟苯甲酯的化妆水样品(NI-0.2),含有浓度为0.6%的苯氧乙醇的化妆水样品(BEN-0.6),含有浓度为0.8%的苯氧乙醇的化妆水样品(BEN-0.8).Through the above method, a total of 5 kinds of lotion samples to be tested were prepared, including the lotion sample without any preservatives, the lotion sample containing methyl paraben with a concentration of 0.1% (NI-0.1), and the lotion sample with a concentration of 0.2 The lotion sample containing 0.6% methyl paraben (NI-0.2), the lotion sample containing 0.6% phenoxyethanol (BEN-0.6), and the lotion sample containing 0.8% phenoxyethanol (BEN -0.8).
(3)模拟面部微生态:取类角质层模型,在其上同时接种痤疮丙酸杆菌、金黄色葡萄球菌、表皮葡萄球菌以模拟面部微生态;(3) Simulate facial microecology: Take a cuticle-like model and inoculate it with Propionibacterium acnes, Staphylococcus aureus, and Staphylococcus epidermidis at the same time to simulate facial microecology;
以类角质层模型的顶面面积为基准,按照每1cm2约1×107CFU的痤疮丙酸杆菌、0.5×107CFU的表皮葡萄球菌、2.5×106CFU的金黄色葡萄球的接种量,在类角质层模型上同时接种三种菌,37℃培养箱中培养48h,获得已接种面部菌的类角质层模型。重复15次,获得15个接种面部菌的类角质层模型。Based on the top surface area of the stratum corneum model, inoculate approximately 1×10 7 CFU of Propionibacterium acnes, 0.5×10 7 CFU of Staphylococcus epidermidis, and 2.5×10 6 CFU of Staphylococcus aureus per 1 cm 2 amount, inoculate three kinds of bacteria on the cuticle-like model at the same time, and culture it in a 37°C incubator for 48 hours to obtain a cuticle-like model that has been inoculated with facial bacteria. Repeat 15 times to obtain 15 stratum corneum-like models inoculated with facial bacteria.
以类角质层模型的顶面面积为基准,按照每1cm2约50μL的量,将5种待测化妆水样品分加入5个已接种面部菌的角质层模型中,并设置3个重复。37℃培养24h,检测模型上细菌的数量。如图16所示,化妆水中加入防腐剂会明显降低三种菌的数量,说明苯氧乙醇或羟苯甲酯防腐剂加入化妆品中会影响面部菌群,随着防腐剂浓度的增加,面部菌群的生长抑制程度也增加。Based on the top surface area of the cuticle-like model, add the five lotion samples to be tested into five cuticle models that have been inoculated with facial bacteria at an amount of approximately 50 μL per 1 cm2 , and set up three replicates. Incubate at 37°C for 24 hours and detect the number of bacteria on the model. As shown in Figure 16, adding preservatives to lotion water will significantly reduce the number of three bacteria, indicating that adding phenoxyethanol or methylparaben preservatives to cosmetics will affect the facial flora. As the concentration of preservatives increases, facial bacteria The degree of growth inhibition of the group also increased.
本实施例将三种面部常见的细菌接种在类角质层上共同培养,用于体外评价含苯氧乙醇或羟苯甲酯防腐剂的化妆水对面部菌群的影响,通过实验表明使用含苯氧乙醇或羟苯甲酯防腐剂的化妆水可能会抑制面部菌群的生长,破坏面部微生态。In this example, three common facial bacteria were inoculated on the stratum corneum and co-cultured for in vitro evaluation of the impact of lotions containing phenoxyethanol or methylparaben preservatives on facial flora. The experiment showed that the use of lotions containing benzene Lotions containing oxyethanol or methylparaben preservatives may inhibit the growth of facial flora and destroy the facial microecology.
化妆品中的防腐剂可以改变皮肤微生物群的平衡,但可以通过体外模型测试不同的防腐剂组合对皮肤常驻菌群动态的影响,可为化妆品配方中正确选择防腐剂和剂量以保持或恢复皮肤微生物的稳态提供参考。Preservatives in cosmetics can alter the balance of the skin microbiota, but the effects of different preservative combinations on the dynamics of the skin's resident flora can be tested through in vitro models, allowing for the correct selection and dosage of preservatives in cosmetic formulations to maintain or restore skin. Provide reference for the homeostasis of microorganisms.
实施例4 Example 4
本实施例提供一种3D类角质层模型的构建方法,包括以下步骤:This embodiment provides a method for constructing a 3D stratum corneum-like model, which includes the following steps:
(1)甲基丙烯酸化胶原蛋白(CMA)、硫酸软骨素甲基丙烯酸酯(CSMA)、甲基丙烯酸缩水甘油酯(GMA)、甲基丙烯酰化透明质酸(HAMA)合成:分别在胶原、硫酸软骨素(CS)、明胶、透明质酸(HA)引入甲基丙烯酸酯基团,合成可光固化凝胶CMA、CSMA、GMA、HAMA。(1) Synthesis of methacrylated collagen (CMA), chondroitin sulfate methacrylate (CSMA), glycidyl methacrylate (GMA), and methacrylated hyaluronic acid (HAMA): respectively in collagen , chondroitin sulfate (CS), gelatin, and hyaluronic acid (HA) are introduced into methacrylate groups to synthesize photocurable gels CMA, CSMA, GMA, and HAMA.
(2)人原代角质层细胞、人永生化角质形成细胞系、人原代皮脂腺细胞、人永生化皮脂腺细胞系、人原代成纤维细胞、人永生化成纤维细胞系培养收集步骤:(2) Culture and collection steps for human primary keratinocytes, human immortalized keratinocyte cell lines, human primary sebaceous gland cells, human immortalized sebaceous gland cell lines, human primary fibroblasts, and human immortalized fibroblast cell lines:
细胞均用DMEM完全培养液于37±0.5℃、5%CO2及饱和湿度的CO2培养箱内培养,培养至细胞融合度达到80%-90%进行收集细胞,除去原培养基,加入PBS缓冲液润洗两遍,加入含EDTA胰蛋白酶消化6~8min,加入完全培养基终止消化,离心收集细胞,用PBS缓冲液润洗两遍,除去培养基。Cells were cultured in DMEM complete culture medium at 37±0.5°C, 5% CO2 and saturated humidity in a CO2 incubator. Culture until the cell confluence reaches 80%-90%. Collect the cells, remove the original culture medium, and add PBS. Rinse twice with buffer, add EDTA-containing trypsin for digestion for 6 to 8 minutes, add complete culture medium to terminate digestion, collect cells by centrifugation, rinse twice with PBS buffer, and remove the culture medium.
(3)建立类角质层模型:取100μL 5~50mg/mL可光固化凝胶CMA、CSMA、GMA、HAMA加入0.15%~0.6%的光引发剂LAP或I2959,放入含有琼脂凝胶的24孔板孔中,在紫外灯下照射5~120s,固化后再加入混合均匀的足量角质细胞、皮脂腺细胞或成纤维细胞,放入37℃生化培养箱干燥12~48h。(3) Establish a stratum corneum model: Take 100 μL of 5-50 mg/mL photocurable gels CMA, CSMA, GMA, and HAMA, add 0.15% to 0.6% of the photoinitiator LAP or I2959, and put it into 24 In the hole of the well plate, irradiate it under ultraviolet light for 5 to 120 seconds. After solidification, add a sufficient amount of keratinocytes, sebaceous gland cells or fibroblasts that are evenly mixed, and place it in a 37°C biochemical incubator to dry for 12 to 48 hours.
可光固化凝胶CMA、GMHA、CSMA、GMA、人原代角质层细胞、人原代皮脂腺细胞、人原代成纤维细胞、人永生化成纤维细胞同样可用于3D类角质层模型证明如下:Photocurable gels CMA, GMHA, CSMA, GMA, human primary keratinocytes, human primary sebaceous gland cells, human primary fibroblasts, and human immortalized fibroblasts can also be used in 3D stratum corneum-like models as demonstrated below:
(1)可光固化凝胶成胶性评价(1) Evaluation of gel-forming properties of photocurable gel
取可光固化凝胶CMA加入光引发剂,在紫外灯下照射5~120s,固化形成凝胶。Take the photocurable gel CMA, add a photoinitiator, and irradiate it under a UV lamp for 5 to 120 seconds to solidify to form a gel.
取可光固化凝胶CSMA加入光引发剂,在紫外灯下照射5~120s,固化形成凝胶。Take the photocurable gel CSMA, add a photoinitiator, and irradiate it under a UV lamp for 5 to 120 seconds to solidify to form a gel.
可光固化凝胶CMA、GMHA、CSMA、GMA均有文献报道能形成凝胶。Photocurable gels CMA, GMHA, CSMA, and GMA have been reported in the literature to be able to form gels.
(2)凝胶及细胞与面部菌生物相容性评价(2) Evaluation of biocompatibility of gel and cells with facial bacteria
面部菌培养:选择痤疮丙酸杆菌、金黄色葡萄球菌、表皮葡萄球菌作为面部菌;痤疮丙酸杆菌使用增强梭状丙酸杆菌液体培养基在厌氧产气袋中37℃培养48h,培养后取菌液离心去上清,重新混悬配置成一定的浓度的菌液。金黄色葡萄球菌使用胰酪大豆胨液体培养基37℃培养24h,培养后取菌液离心去上清,重新混悬配置成一定的浓度的菌液。表皮葡萄球菌使用LB液体培养基37℃培养24h,培养后取菌液离心去上清,重新混悬配置成一定的浓度的菌液。Facial bacteria culture: Select Propionibacterium acnes, Staphylococcus aureus, and Staphylococcus epidermidis as facial bacteria; Propionibacterium acnes is cultured in an anaerobic gas-generating bag at 37°C for 48 hours using enhanced Clostridium propionibacterium liquid culture medium. Centrifuge the bacterial liquid to remove the supernatant, and resuspend the bacterial liquid to a certain concentration. Staphylococcus aureus is cultured in tryptic soybean liquid medium at 37°C for 24 hours. After culture, the bacterial liquid is centrifuged to remove the supernatant, and the bacterial liquid is resuspended to a certain concentration. Staphylococcus epidermidis was cultured in LB liquid medium at 37°C for 24 hours. After culture, the bacterial liquid was centrifuged to remove the supernatant, and the bacterial liquid was resuspended to a certain concentration.
(2.2)将100μL一定浓度的可光固化凝胶溶液与等量的人原代角质层细胞、人原代皮脂腺细胞、人原代成纤维细胞、人永生化成纤维细胞(HSF细胞)各约2×104个细胞混合加入到96孔板在中,control组为细菌培养基。分别将几种细菌重悬在相应培养基中(OD600约0.06),加入100μL到可光固化凝胶溶液中,在96孔板中37℃共培养 24h~48h,培养后涡旋30min,之后800rpm离心5min,取上清液100μL使用酶标仪测定600nm时菌液的吸光度。与control组相比如果凝胶溶液组的菌液浓度没有明显降低,则说明所用凝胶、细胞与细菌之间具有良好的生物相容性,可以用于构建可供微生物生长的3D类角质层模型。已有文献报道可光固化凝胶CMA、GMHA、CSMA、GMA均有良好的细胞相容性,凝胶包载的细胞可正常生长。(2.2) Mix 100 μL of a certain concentration of photocurable gel solution with an equal amount of human primary stratum corneum cells, human primary sebaceous gland cells, human primary fibroblasts, and human immortalized fibroblasts (HSF cells) for about 2 times each. ×10 4 cells were mixed and added to a 96-well plate, and the control group was bacterial culture medium. Resuspend several bacteria in the corresponding culture medium (OD 600 is about 0.06), add 100 μL to the photocurable gel solution, and co-culture in a 96-well plate at 37°C. 24h to 48h, vortex for 30 minutes after incubation, and then centrifuge at 800 rpm for 5 minutes. Take 100 μL of the supernatant and use a microplate reader to measure the absorbance of the bacterial solution at 600 nm. If the concentration of bacterial solution in the gel solution group is not significantly reduced compared with the control group, it means that the gel, cells and bacteria used have good biocompatibility and can be used to construct a 3D cuticle-like layer for microbial growth. Model. It has been reported in the literature that photocurable gels CMA, GMHA, CSMA, and GMA all have good cell compatibility, and cells encapsulated in the gel can grow normally.
图19为将一定浓度的CMA或CSMA与人原代角质层细胞、人原代皮脂腺细胞、人原代成纤维细胞、人永生化成纤维细胞(HSF细胞)混合后与痤疮丙酸杆菌在96孔板中厌氧培养48h的菌液。Figure 19 shows a mixture of a certain concentration of CMA or CSMA with human primary keratinocytes, human primary sebaceous gland cells, human primary fibroblasts, human immortalized fibroblasts (HSF cells) and then mixed with Propionibacterium acnes in 96 wells. Bacterial liquid cultured anaerobically in the plate for 48 hours.
图20为将一定浓度的CMA或CSMA与人原代角质层细胞、人原代皮脂腺细胞、人原代成纤维细胞、人永生化成纤维细胞(HSF细胞)混合后与表皮葡萄球菌在96孔板中培养24h的菌液。Figure 20 shows a mixture of a certain concentration of CMA or CSMA with human primary keratinocytes, human primary sebaceous gland cells, human primary fibroblasts, and human immortalized fibroblasts (HSF cells) and then incubated with Staphylococcus epidermidis in a 96-well plate. Bacterial liquid cultured for 24 hours.
实施例5Example 5
将实施例2中建立的类角质层用于微生物定殖形成生物膜检测:The cuticle-like layer established in Example 2 was used for detection of microbial colonization and biofilm formation:
将不同浓度的的马拉色菌接种到模型上,在35℃生化培养箱培养,分别在培养第0天、1天、3天、5天、7天,9天通过平板计数法检测真菌数目。具体操作方法为将模型用刀切碎,放入15mL离心管中,加入6mL PBS缓冲液,涡旋30min洗脱分离出细菌。将菌液用PBS混悬,稀释数个倍数,分别涂布到橄榄油培养基平板上,恒温培养箱培养48h,对平板上长出的菌落数计数,根据平板计数法计算出菌液的数目。通过图21可以看出马拉色菌能在类角质层上存活,并能在一定范围内维持稳态。Different concentrations of Malassezia were inoculated into the model and cultured in a 35°C biochemical incubator. The number of fungi was detected by plate counting on days 0, 1, 3, 5, 7, and 9 of culture. . The specific operation method is to chop the model into pieces with a knife, put it into a 15mL centrifuge tube, add 6mL of PBS buffer, and vortex for 30 minutes to elute and isolate the bacteria. Suspend the bacterial liquid with PBS, dilute it several times, spread it on the olive oil culture medium plate, incubate it in a constant temperature incubator for 48 hours, count the number of bacterial colonies growing on the plate, and calculate the number of bacterial liquid according to the plate counting method. . It can be seen from Figure 21 that Malassezia can survive on the cuticle and maintain a steady state within a certain range.
实施例6Example 6
本实施例提供一种模拟皮肤表面微生物的组成的方法,该方法通过在类角质层上连续多次接种面部菌群,即可获得类似真实皮肤的表面微生物组成,从而达到模拟皮肤表面微生物的组成的目的。This embodiment provides a method for simulating the composition of microorganisms on the skin surface. This method can obtain a surface microbial composition similar to that of real skin by continuously inoculating facial flora on the stratum corneum layer multiple times, thereby simulating the composition of microorganisms on the skin surface. the goal of.
具体的,将实施例2中建立的类角质层采用连续多次接种面部菌群的方法以模拟皮肤表面微生物的组成:Specifically, the stratum corneum-like layer established in Example 2 was continuously inoculated with facial flora multiple times to simulate the composition of microorganisms on the skin surface:
所述模拟皮肤表面微生物的组成的方法包括以下步骤:The method of simulating the composition of microorganisms on the skin surface includes the following steps:
(1)使用棉拭子从人面部收集菌群,将菌群连续多次接种到3D类角质层模型上,连续培养4天,分别在第0天、第1天、第2天、第3天从人面部收集菌群并接种到模型上培养。(1) Use cotton swabs to collect bacterial flora from the human face, inoculate the bacterial flora onto the 3D stratum corneum model multiple times, and culture for 4 consecutive days. The bacterial flora were collected from human faces and inoculated onto the model for culture.
(2)在第0天、第1天、第4天从模型上收集菌群,将模型用刀切碎,放入15mL离心管中,加入6mL PBS缓冲液,涡旋30min洗脱分离出菌群。将菌液用PBS重悬菌群,向混悬液中加入PMA溶液,避光混匀后常温孵育10min,500W钨光灯光照10min。(2) Collect bacterial colonies from the model on days 0, 1, and 4, chop the model into pieces with a knife, put it into a 15mL centrifuge tube, add 6mL PBS buffer, vortex for 30 minutes, and elute and isolate the bacteria. group. Resuspend the bacterial colony in PBS, add PMA solution to the suspension, mix well in the dark, and incubate at room temperature for 10 minutes, then illuminate with 500W tungsten light for 10 minutes.
(3)离心收集菌群,使用Bacteria DNA isolation Mini Kit试剂盒按照说明书方法提取细菌DNA,使用16Sr RNA测序技术对微生物群落进行检测并分析(n=4)。(3) Collect the bacterial colonies by centrifugation, use the Bacteria DNA isolation Mini Kit to extract bacterial DNA according to the instructions, and use 16Sr RNA sequencing technology to detect and analyze the microbial communities (n=4).
从人面部取得的菌群在经过连续多次接种到模型上后,将形成与初始菌群相似的群 落,微生物菌群在接种培养一天后菌群组成发生变化,但经过连续四天培养之后,在3D类角质层模型形成与初始菌群相似的菌群组成。如图22所示,培养第0天和第一天组间存在显著性差异(anosim检验,P<0.05),培养第0天和第四天组间相似,没有显著性差异(anosim检验,P>0.05)。After the bacterial flora obtained from the human face is inoculated onto the model several times in a row, it will form a group similar to the initial flora. The composition of the microbial flora changed after one day of inoculation and culture, but after four days of continuous culture, the 3D cuticle-like model formed a flora composition similar to the initial flora. As shown in Figure 22, there is a significant difference between the groups on the 0th day of culture and the first day (anosim test, P<0.05). The groups are similar on the 0th day and the fourth day of culture, and there is no significant difference (anosim test, P >0.05).
图23是非量度多维尺度分析(NMDS)分析结果,通过二维排序图展示微生物群落的组成差异。图23中两点之间的距离越近(远),表明两个样本中微生物群落的差异越小(大),可以看出day0与day4之间微生物群落的组成差异较小。Figure 23 is the result of non-metric multidimensional scaling analysis (NMDS), showing the compositional differences of microbial communities through a two-dimensional ordination diagram. The closer (far) the distance between the two points in Figure 23 is, the smaller (larger) the difference in the microbial communities in the two samples is. It can be seen that the compositional difference in the microbial communities between day0 and day4 is small.
从图24可以看出与第0天菌群相比,从人面部收集的菌群在3D类角质层模型培养一天后,菌群中相对丰度排名前二十的属丰度占比发生显著变化。而在3D类角质层模型培养至第四天时,相对丰度排名前二十的属丰度占比与第0天非常相似。It can be seen from Figure 24 that compared with the bacterial flora on day 0, after one day of culture of the bacterial flora collected from the human face in the 3D cuticle-like model, the abundance of the top twenty genera with relative abundance in the bacterial flora changed significantly. Variety. When the 3D cuticle model was cultured on the fourth day, the abundance proportions of the top twenty genera with relative abundance were very similar to those on day 0.
从图22、图23和图24可知,通过在3D类角质层模型上采用连续多次接种面部菌群的方法可以在3D类角质层模型上复刻皮肤表面菌群。 It can be seen from Figures 22, 23 and 24 that by inoculating the facial flora multiple times on the 3D stratum corneum-like model, the skin surface flora can be reproduced on the 3D stratum corneum-like model.

Claims (10)

  1. 一种3D类角质层模型,其特征在于,所述3D类角质层模型包括可光固化凝胶骨架,所述可光固化凝胶骨架负载有凋亡细胞/或细胞衍生物;所述可光固化凝胶骨架由可被照射光引发交联的侧链含有双键的生物大分子构成。A 3D stratum corneum-like model, characterized in that the 3D stratum corneum-like model includes a photocurable gel skeleton, and the photocurable gel skeleton is loaded with apoptotic cells/or cell derivatives; the photocurable gel skeleton is The solidified gel skeleton is composed of biomacromolecules with double bonds in their side chains that can be cross-linked by irradiation with light.
  2. 根据权利要求1所述的3D类角质层模型,其特征在于,所述可光固化凝胶骨架构成的孔隙的孔径为1~500μm。The 3D stratum corneum-like model according to claim 1, wherein the pores formed by the photocurable gel skeleton have a pore diameter of 1 to 500 μm.
  3. 根据权利要求1所述的3D类角质层模型,其特征在于,所述3D类角质层模型厚度为10μm~1mm。The 3D stratum corneum-like model according to claim 1, wherein the thickness of the 3D stratum corneum-like model is 10 μm to 1 mm.
  4. 根据权利要求1所述的3D类角质层模型,其特征在于,所述细胞为皮脂腺细胞和皮肤角质细胞。The 3D stratum corneum-like model according to claim 1, wherein the cells are sebaceous gland cells and skin keratinocytes.
  5. 根据权利要求4所述的3D类角质层模型,其特征在于,皮肤角质细胞占3D类角质层模型中细胞总量的10%~90%。The 3D stratum corneum-like model according to claim 4, wherein skin keratinocytes account for 10% to 90% of the total number of cells in the 3D stratum corneum-like model.
  6. 一种根据权利要求1-5任一所述的3D类角质层模型的构建方法,其特征在于,包括以下步骤:将可光固化凝胶与凋亡的角质细胞和皮脂腺细胞光固化,即得3D类角质层模型。A method for constructing a 3D stratum corneum-like model according to any one of claims 1 to 5, characterized in that it includes the following steps: photocuring a photocurable gel with apoptotic keratinocytes and sebaceous gland cells to obtain 3D cuticle-like model.
  7. 根据权利要求6所述的3D类角质层模型的构建方法,其特征在于,所述的光固化方法为5~50mg/mL可光固化凝胶加入0.15%~0.3%的光引发剂,放入孔板中,在光照射的条件下,加入混合均匀的角质细胞和皮脂腺细胞,恒温干燥。The method for constructing a 3D stratum corneum-like model according to claim 6, characterized in that the photocuring method is to add 0.15% to 0.3% photoinitiator to 5-50 mg/mL photo-curable gel, and put In the well plate, under the condition of light irradiation, add uniformly mixed keratinocytes and sebaceous gland cells, and dry at a constant temperature.
  8. 根据权利要求6所述的3D类角质层模型的构建方法,其特征在于,所述的光固化方法为0.15%~0.3%的光引发剂与若干个角质细胞和皮脂腺细胞混合均匀,得到的混合溶液加入到5~50mg/mL可光固化凝胶中,放入孔板中,在光照射的条件下,后加入足量细胞,恒温干燥,所述引发剂为LAP、I2959中的任一种。The method for constructing a 3D stratum corneum-like model according to claim 6, characterized in that the photocuring method is to mix 0.15% to 0.3% of the photoinitiator evenly with several keratinocytes and sebaceous gland cells, and the resulting mixture The solution is added to a 5-50 mg/mL photocurable gel, placed in a well plate, and under light irradiation conditions, a sufficient amount of cells is then added and dried at a constant temperature. The initiator is any one of LAP and I2959. .
  9. 一种根据权利要求1-5任一所述的3D类角质层模型在化妆品或其原料功效体外评价、化妆品活性成分功效筛选或生物制剂药效评价中的应用。An application of the 3D stratum corneum-like model according to any one of claims 1 to 5 in in vitro evaluation of the efficacy of cosmetics or their raw materials, efficacy screening of cosmetic active ingredients, or efficacy evaluation of biological preparations.
  10. 根据权利要求9所述的应用,其特征在于,所述应用的方法,包括以下步骤:The application according to claim 9, characterized in that the application method includes the following steps:
    (1)在3D类角质层模型上接种若干种面部菌以模拟面部微生态;(1) Inoculate several kinds of facial bacteria on the 3D stratum corneum model to simulate the facial microecology;
    (2)在已接种面部菌的3D类角质层模型上,涂覆待测试样品;(2) Coat the sample to be tested on the 3D stratum corneum model that has been inoculated with facial bacteria;
    (3)一段时间后,检测3D类角质层模型上细菌的数量或菌群每种菌的相对丰度,获得的结果用于评价或筛选测试样品。 (3) After a period of time, detect the number of bacteria on the 3D cuticle-like model or the relative abundance of each bacteria in the bacterial community, and the results obtained are used to evaluate or screen the test samples.
PCT/CN2023/098261 2022-06-23 2023-06-05 3d stratum corneum-like model, construction method therefor and use thereof WO2023246485A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CN202210716687.3 2022-06-23
CN202210716687.3A CN115161258A (en) 2022-06-23 2022-06-23 3D (three-dimensional) horny layer model and construction method and application thereof
CN202310221547.3A CN116286602A (en) 2022-06-23 2023-03-09 3D (three-dimensional) stratum corneum model and construction method and application thereof
CN202310221547.3 2023-03-09

Publications (1)

Publication Number Publication Date
WO2023246485A1 true WO2023246485A1 (en) 2023-12-28

Family

ID=83486375

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2023/098261 WO2023246485A1 (en) 2022-06-23 2023-06-05 3d stratum corneum-like model, construction method therefor and use thereof

Country Status (2)

Country Link
CN (2) CN115161258A (en)
WO (1) WO2023246485A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115161258A (en) * 2022-06-23 2022-10-11 中国药科大学 3D (three-dimensional) horny layer model and construction method and application thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016039687A1 (en) * 2014-09-10 2016-03-17 National University Of Singapore Organotypic skin model
WO2017214592A1 (en) * 2016-06-09 2017-12-14 Paul Gatenholm Preparation of modified cellulose nanofibrils with extracellular matrix components as 3d bioprinting bioinks
CN109749983A (en) * 2018-12-17 2019-05-14 中国人民解放军总医院 A kind of method appendicle activity in raising artificial skin and control its distribution
CN113950339A (en) * 2019-06-13 2022-01-18 塞林克公司 3D biological printing skin tissue model
CN115161258A (en) * 2022-06-23 2022-10-11 中国药科大学 3D (three-dimensional) horny layer model and construction method and application thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016039687A1 (en) * 2014-09-10 2016-03-17 National University Of Singapore Organotypic skin model
WO2017214592A1 (en) * 2016-06-09 2017-12-14 Paul Gatenholm Preparation of modified cellulose nanofibrils with extracellular matrix components as 3d bioprinting bioinks
CN109749983A (en) * 2018-12-17 2019-05-14 中国人民解放军总医院 A kind of method appendicle activity in raising artificial skin and control its distribution
CN113950339A (en) * 2019-06-13 2022-01-18 塞林克公司 3D biological printing skin tissue model
CN115161258A (en) * 2022-06-23 2022-10-11 中国药科大学 3D (three-dimensional) horny layer model and construction method and application thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HU JINHUA; WANG LING; SHI RAN; XU MINGEN: "The State-of-the-art of 3D Bio-printing of Skin Tissues", SCIENCE CHINA: CHINESE BULLETIN OF LIFE SCIENCE = SCIENTIA SINICA VITAE, vol. 47, no. 4, 31 December 2017 (2017-12-31), pages 423 - 442, XP009551290, ISSN: 1674-7232 *
PETTA D, D’AMORA U, AMBROSIO L, GRIJPMA D W, EGLIN D, D’ESTE M: "Hyaluronic acid as a bioink for extrusion-based 3D printing", BIOFABRICATION, vol. 12, no. 3, pages 032001, XP055915864, DOI: 10.1088/1758-5090/ab8752 *

Also Published As

Publication number Publication date
CN115161258A (en) 2022-10-11
CN116286602A (en) 2023-06-23

Similar Documents

Publication Publication Date Title
JP6713065B2 (en) Probiotic composition, skin care essence and mask, and method for producing the same
WO2023246485A1 (en) 3d stratum corneum-like model, construction method therefor and use thereof
CN112451431A (en) Composition for balancing skin micro-ecology and preparation method and application thereof
KR20200096807A (en) Probiotic composition and use thereof
CN115105452B (en) Black tea fermentation filtrate and preparation method and application thereof
CN107988115B (en) Lactobacillus plantarum and composite probiotic fermentation liquor and preparation method thereof
CN103462876A (en) Cosmetic or dermatological composition comprising a cell culture medium
CN115554226B (en) Multi-strain fermentation filtrate and preparation method and application thereof
KR102149102B1 (en) Method of preparing dermobiotics block composition for skin hydration and skin regeneration
WO2017182208A1 (en) In vitro full-skin model containing three-dimensional cell culture models of the sweat gland
JP5124440B2 (en) External preparation for skin containing flavanone derivative
WO2007090575A1 (en) Skin model with dendritic cells
CN109172613B (en) Skin external composition containing lactobacillus dead bacteria culture and its use for promoting wound healing and reducing scar generation
Liu et al. 3D printed lactic acid bacteria hydrogel: cell release kinetics and stability
CN114891699A (en) Lactobacillus salivarius for regulating flora balance
CN114262675A (en) Preparation of composite bacteria fermentation filtrate and application of whitening effect of composite bacteria fermentation filtrate in cosmetics
CN114099413A (en) Probiotic and tea polyphenol compound composition, preparation and application thereof
TWI712415B (en) Topical composition, medicinal composition containing inactivated culture and use thereof for facilitating wound healing and scar reduction
PL243163B1 (en) Cosmetic product containing live probiotic bacteria, consisting of two phases and its use
WO2001092476A2 (en) In vitro tissue test system
CN114517162A (en) Candida salivarius, fermentation product and application thereof
Linton et al. A silicon cell cycle in a bacterial model of calcium phosphate mineralogenesis
JP2008120725A (en) External preparation for skin
US20240035063A1 (en) Synthetic mixed culture resembling a skin microbiome
CN114903839B (en) Facial essence containing bifidobacterium lactis fermentation product

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 23826134

Country of ref document: EP

Kind code of ref document: A1